WW International (WW) 10-Q 2 Nov 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Oct. 26, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Trading Symbol	WW
Entity Registrant Name	WW INTERNATIONAL, INC.
Entity Central Index Key	0000105319
Current Fiscal Year End Date	--12-30
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		79,081,017
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-16769
Entity Incorporation, State or Country Code	VA
Entity Tax Identification Number	11-6040273
Entity Address, Address Line One	675 Avenue of the Americas
Entity Address, Address Line Two	6th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10010
City Area Code	212
Local Phone Number	589-2700
Title of 12(b) Security	Common Stock, no par value
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Document Quarterly Report	true
Document Transition Report	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 107,498	$ 178,326
Receivables (net of allowances: September 30, 2023 - $1,435 and December 31, 2022 - $976)	19,178	24,273
Inventories	10,141	20,528
Prepaid income taxes	53,880	19,447
Prepaid expenses and other current assets	28,092	38,757
TOTAL CURRENT ASSETS	218,789	281,331
Property and equipment, net	22,608	28,229
Operating lease assets	55,414	75,696
Franchise rights acquired	386,168	386,745
Goodwill	244,927	155,998
Other intangible assets, net	66,532	63,306
Deferred income taxes	20,728	22,246
Other noncurrent assets	17,087	14,879
TOTAL ASSETS	1,032,253	1,028,430
CURRENT LIABILITIES
Portion of operating lease liabilities due within one year	9,804	17,955
Accounts payable	19,732	18,890
Salaries and wages payable	61,794	72,577
Accrued marketing and advertising	13,645	17,927
Accrued interest	10,969	5,289
Other accrued liabilities	44,569	30,118
Income taxes payable	987	1,646
Deferred revenue	32,445	32,156
TOTAL CURRENT LIABILITIES	193,945	196,558
Long-term debt, net	1,425,419	1,422,284
Long-term operating lease liabilities	56,643	68,099
Deferred income taxes	15,932	25,084
Other	15,481	2,185
TOTAL LIABILITIES	1,707,420	1,714,210
TOTAL DEFICIT
Common stock, $0 par value; 1,000,000 shares authorized; 130,048 shares issued at September 30, 2023 and 122,052 shares issued at December 31, 2022	0	0
Treasury stock, at cost, 51,030 shares at September 30, 2023 and 51,496 shares at December 31, 2022	(3,073,196)	(3,097,304)
Retained earnings	2,409,997	2,416,994
Accumulated other comprehensive loss	(11,968)	(5,470)
TOTAL DEFICIT	(675,167)	(685,780)
TOTAL LIABILITIES AND TOTAL DEFICIT	$ 1,032,253	$ 1,028,430

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Receivables, allowances	$ 1,435	$ 976
Common stock, par value	$ 0	$ 0
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	130,048,000	122,052,000
Treasury stock, shares	51,030,000	51,496,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Revenues, net	$ 214,871	$ 249,718	$ 683,594	$ 816,932
Cost of revenues	73,116	97,367	279,148	321,521
Gross profit	141,755	152,351	404,446	495,411
Marketing expenses	48,114	35,696	187,468	195,123
Selling, general and administrative expenses	63,034	58,443	188,638	193,320
Franchise rights acquired and goodwill impairments		312,741		339,161
Operating income (loss)	30,607	(254,529)	28,340	(232,193)
Interest expense	24,508	20,912	71,429	58,837
Other expense (income), net	815	1,344	(36)	3,303
Income (loss) before income taxes	5,284	(276,785)	(43,053)	(294,333)
Benefit from income taxes	(38,447)	(70,749)	(18,933)	(73,246)
Net income (loss)	$ 43,731	$ (206,036)	$ (24,120)	$ (221,087)
Earnings (net loss) per share
Basic	$ 0.55	$ (2.93)	$ (0.32)	$ (3.15)
Diluted	$ 0.54	$ (2.93)	$ (0.32)	$ (3.15)
Weighted average common shares outstanding
Basic	78,979	70,383	75,861	70,258
Diluted	80,638	70,383	75,861	70,258
Subscription
Revenues, net	$ 203,496	$ 220,746	$ 626,667	$ 718,122
Cost of revenues	67,080	73,541	233,354	243,710
Product and Other
Revenues, net	11,375	28,972	56,927	98,810
Cost of revenues	$ 6,036	$ 23,826	$ 45,794	$ 77,811

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 43,731	$ (206,036)	$ (24,120)	$ (221,087)
Other comprehensive (loss) gain:
Foreign currency translation loss	(2,639)	(9,552)	(1,710)	(18,018)
Income tax benefit on foreign currency translation loss	660	2,406	428	4,530
Foreign currency translation loss, net of taxes	(1,979)	(7,146)	(1,282)	(13,488)
(Loss) gain on derivatives	(3,280)	8,590	(6,955)	27,748
Income tax benefit (expense) on (loss) gain on derivatives	820	(2,159)	1,739	(6,973)
(Loss) gain on derivatives, net of taxes	(2,460)	6,431	(5,216)	20,775
Total other comprehensive (loss) gain	(4,439)	(715)	(6,498)	7,287
Comprehensive income (loss)	$ 39,292	$ (206,751)	$ (30,618)	$ (213,800)

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL DEFICIT - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance at Jan. 01, 2022	$ (452,904)	$ 0	$ (3,120,149)	$ (18,604)	$ 2,685,849
Beginning balance (in shares) at Jan. 01, 2022		122,052	51,988
Comprehensive (loss) income	(213,800)			7,287	(221,087)
Issuance of treasury stock under stock plans	(1,846)		$ 14,051		(15,897)
Issuance of treasury stock under stock plans (in shares)			(321)
Compensation expense on share-based awards	10,362				10,362
Ending balance at Oct. 01, 2022	(658,188)	$ 0	$ (3,106,098)	(11,317)	2,459,227
Ending balance (in shares) at Oct. 01, 2022		122,052	51,667
Beginning balance at Jan. 01, 2022	(452,904)	$ 0	$ (3,120,149)	(18,604)	2,685,849
Beginning balance (in shares) at Jan. 01, 2022		122,052	51,988
Comprehensive (loss) income	(243,734)
Ending balance at Dec. 31, 2022	(685,780)	$ 0	$ (3,097,304)	(5,470)	2,416,994
Ending balance (in shares) at Dec. 31, 2022		122,052	51,496
Beginning balance at Jul. 02, 2022	(454,793)	$ 0	$ (3,107,324)	(10,602)	2,663,133
Beginning balance (in shares) at Jul. 02, 2022		122,052	51,691
Comprehensive (loss) income	(206,751)			(715)	(206,036)
Issuance of treasury stock under stock plans	(20)		$ 1,226		(1,246)
Issuance of treasury stock under stock plans (in shares)			(24)
Compensation expense on share-based awards	3,376				3,376
Ending balance at Oct. 01, 2022	(658,188)	$ 0	$ (3,106,098)	(11,317)	2,459,227
Ending balance (in shares) at Oct. 01, 2022		122,052	51,667
Beginning balance at Dec. 31, 2022	(685,780)	$ 0	$ (3,097,304)	(5,470)	2,416,994
Beginning balance (in shares) at Dec. 31, 2022		122,052	51,496
Comprehensive (loss) income	(30,618)			(6,498)	(24,120)
Issuance of treasury stock under stock plans	(668)		$ 24,108		(24,776)
Issuance of treasury stock under stock plans (in shares)			(466)
Compensation expense on share-based awards	8,956				8,956
Issuance of common stock	32,943				32,943
Issuance of common stock (in shares)		7,996
Ending balance at Sep. 30, 2023	(675,167)	$ 0	$ (3,073,196)	(11,968)	2,409,997
Ending balance (in shares) at Sep. 30, 2023		130,048	51,030
Beginning balance at Jul. 01, 2023	(718,227)	$ 0	$ (3,079,073)	(7,529)	2,368,375
Beginning balance (in shares) at Jul. 01, 2023		130,048	51,146
Comprehensive (loss) income	39,292			(4,439)	43,731
Issuance of treasury stock under stock plans	543		$ 5,877		(5,334)
Issuance of treasury stock under stock plans (in shares)			(116)
Compensation expense on share-based awards	3,225				3,225
Ending balance at Sep. 30, 2023	$ (675,167)	$ 0	$ (3,073,196)	$ (11,968)	$ 2,409,997
Ending balance (in shares) at Sep. 30, 2023		130,048	51,030

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Operating activities:
Net loss	$ 43,731	$ (206,036)	$ (24,120)	$ (221,087)
Adjustments to reconcile net loss to cash (used for) provided by operating activities:
Depreciation and amortization			39,805	33,371
Amortization of deferred financing costs and debt discount			3,763	3,763
Impairment of franchise rights acquired and goodwill		312,741		339,161
Impairment of intangible and long-lived assets			197	2,088
Share-based compensation expense			12,838	10,362
Deferred tax benefit			(7,449)	(107,879)
Allowance for doubtful accounts			407	54
Reserve for inventory obsolescence			1,897	4,712
Foreign currency exchange rate (gain) loss			(31)	3,562
Changes in cash due to:
Receivables			9,117	(9,760)
Inventories			9,009	(725)
Prepaid expenses			(27,301)	17,613	$ 8,878
Accounts payable			1,221	(3,634)
Accrued liabilities			(17,010)	15,390	20,925
Deferred revenue			309	(3,576)
Other long term assets and liabilities, net			(2,701)	(4,662)
Income taxes			(1,104)	1,793	4,577
Cash (used for) provided by operating activities			(1,153)	80,546	76,646
Investing activities:
Capital expenditures			(2,143)	(1,756)
Capitalized software expenditures			(26,190)	(27,584)
Cash paid for acquisitions, net of cash acquired			(38,362)	(4,350)
Other items, net			(14)	(29)
Cash used for investing activities			(66,709)	(33,719)
Financing activities:
Taxes paid related to net share settlement of equity awards			(1,417)	(1,938)
Proceeds from stock options exercised			710
Cash paid for acquisitions			(1,178)	(113)
Other items, net			(43)	(86)
Cash used for financing activities			(1,928)	(2,137)
Effect of exchange rate changes on cash and cash equivalents			(1,038)	(10,193)
Net (decrease) increase in cash and cash equivalents			(70,828)	34,497
Cash and cash equivalents, beginning of period			178,326	153,794	153,794
Cash and cash equivalents, end of period	$ 107,498	$ 188,291	$ 107,498	$ 188,291	$ 178,326

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 43,731	$ (35,780)	$ (206,036)	$ (24,120)	$ (221,087)	$ (256,868)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2023
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	From time to time, our directors and officers may engage in open-market transactions with respect to their Company equity holdings for diversification or other personal reasons. All such transactions by directors and officers must comply with the Company’s Amended and Restated Securities Trading Policy, which requires that such transactions be in accordance with applicable U.S. federal securities laws that prohibit trading while in possession of material nonpublic information. Rule 10b5-1 under the Exchange Act provides an affirmative defense that enables directors and officers to prearrange transactions in the Company’s securities in a manner that avoids concerns about initiating transactions while in possession of material nonpublic information. No contracts, instructions or written plans for the purchase or sale of Company securities were adopted or terminated by our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) during the quarter ended September 30, 2023, that were intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). No “non-Rule 10b5–1 trading arrangements” (as defined by Item 408(c) of Regulation S-K) or other Rule 10b5-1 trading arrangements were entered into or terminated, nor were any such arrangements modified, by our directors or officers during such period.
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying consolidated financial statements include the accounts of WW International, Inc., all of its subsidiaries and the variable interest entities of which WW International, Inc. is the primary beneficiary (as discussed below). The terms “Company” and “WW” as used throughout these notes are used to indicate WW International, Inc. and all of its operations consolidated for purposes of its financial statements. The Company’s “Digital” business refers to providing subscriptions to the Company’s digital product offerings, which formerly included Digital 360 (as applicable). The Company’s “Workshops + Digital” business refers to providing unlimited access to the Company’s workshops combined with the Company’s digital subscription product offerings to commitment plan subscribers, including former Digital 360 members (as applicable). It also formerly included the provision of access to workshops for members who did not subscribe to commitment plans, which included the Company’s “pay-as-you-go” members. The Company’s “Clinical” business refers to providing subscriptions to the Company’s clinical product offerings included in its Sequence (as defined below) program. In the second quarter of fiscal 2022, the Company ceased offering its Digital 360 product. More than a majority of associated members were transitioned from the Company’s Digital business to its Workshops + Digital business during the second quarter of fiscal 2022, with a de minimis number transitioning during the beginning of the third quarter of fiscal 2022. The cessation of this product offering and these transitions of former Digital 360 members at the then-current pricing for such product impacted the number of End of Period Subscribers in each business as well as the associated Paid Weeks and Revenues for each business. The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and include amounts that are based on management’s best estimates and judgments. While all available information has been considered, actual amounts could differ from those estimates. These assumptions and estimates may change as new events occur and additional information is obtained, and such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity. The consolidated financial statements include all of the Company’s majority-owned subsidiaries. All entities acquired, and any entity of which a majority interest was acquired, are included in the consolidated financial statements from the date of acquisition. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s operating results for any interim period are not necessarily indicative of future or annual results. The consolidated financial statements are unaudited and, accordingly, they do not include all of the information necessary for a comprehensive presentation of results of operations, financial position and cash flow activity required by GAAP for complete financial statements but, in the opinion of management, reflect all adjustments including those of a normal recurring nature necessary for a fair statement of the interim results presented. The Company evaluates its ownership, contractual and other interests in entities to determine if it has any variable interest in a variable interest entity (“VIE” ). These evaluations are complex and involve judgment and the use of estimates and assumptions based on available information. If the Company determines that an entity in which it holds a contractual or ownership interest is a VIE and that the Company is the primary beneficiary, such entity is consolidated in the Company’s consolidated financial statements. The primary beneficiary of a VIE is the party that meets both of the following criteria: (i) has the power to make decisions that most significantly affect the economic performance of the VIE; and (ii) has the obligation to absorb losses or the right to receive benefits that in either case could potentially be significant to the VIE. The Company performs ongoing reassessments of whether changes in the facts and circumstances regarding the Company’s involvement with a VIE will cause the consolidation conclusion to change. The Company operates certain clinical telehealth groups which are deemed to be Friendly-Physician Entities (“FPEs”) and due to legal requirements, the physician-owners must retain 100 % of the equity interest. The Company’s agreements with FPEs generally consist of both an Administrative Service Agreement, which provides for various administrative and management services to be provided by the Company to the FPE, and Stock Transfer Restriction (“STR”) agreements with the physician-owners of the FPEs, which provide for the transition of ownership interest of the FPEs under certain conditions. The Company has the right to receive income as an ongoing management fee, which effectively absorbs all of the residual interests, and can also provide financial support through loans to the FPEs. The Company has exclusive responsibility for the provision of all nonmedical services including technology and intellectual property required for the day-to-day operation and management of each of the FPEs. In addition, the STR agreements provide that the Company has the right to designate a person(s) to purchase the equity interest of the FPE for a nominal amount in the event of a succession event at the Company’s discretion. Based on the provisions of these agreements, the Company determined that the FPEs are VIEs due to their equity holder having insufficient capital at risk, and the Company has a variable interest in the FPEs. The contractual arrangements described above allow Sequence to direct the activities that most significantly affect the economic performance of the FPEs. Accordingly, Sequence is the primary ben eficiary of the FPEs and consolidates the FPEs under the VIE model. Furthermore, as a direct result of nominal initial equity contributions by the physicians, the financial support the Company can provide to the FPEs (e.g., loans) and the provisions of the contractual arrangements and nominee shareholder succession arrangements described above, the interests held by noncontrolling interest holders lack economic substance and do not provide them with the ability to participate in the residual profits or losses generated by the FPEs. Therefore, all income and expenses recognized by the FPEs are consolidated by the Company. The Company does not hold interests in any VIEs for which the Company is not deemed to be the primary beneficiary. With respect to the Company’s previously announced change in segment reporting, segment data for the three and nine months ended October 1, 2022 has been updated to reflect the new reportable segment structure. See Notes 4 and 14 for disclosures related to segments. These statements should be read in conjunction with the Company’s Annual Report on Form 10-K for fiscal 2022 filed on March 6, 2023, which includes additional information about the Company, its results of operations, its financial position and its cash flows. Revision of Previously Issued Consolidated Financial Statements After the three months ended September 30, 2023, the Company identified misstatements in its accounting for income taxes resulting primarily from the recording of a U.S. deferred tax liability related to a foreign branch of the U.S., partially offset by a U.S. deferred tax asset related to its U.S. leases, that should have been recorded in prior fiscal years. The Company evaluated the misstatements and concluded that the misstatements were not material, either individually or in aggregate, to its current or previously issued consolidated financial statements. To correct the immaterial misstatements, the Company has revised its previously issued consolidated financial statements as of and for the year ended December 31, 2022 and its unaudited consolidated financial statements for the nine months ended October 1, 2022. The revision of the historical consolidated financial statements also includes the correction of other immaterial misstatements that the Company had previously recorded as out-of-period adjustments. The Company had previously determined that these previously identified misstatements did not, either individually or in the aggregate, result in a material misstatement of its previously issued consolidated financial statements and reached the same conclusion when aggregating the previously identified misstatements with the recently identified misstatements. See Note 17 for further information regarding the misstatements and related revisions. The accompanying financial statements and relevant notes to the consolidated financial statements for the periods referenced above in this Quarterly Report on Form 10-Q have been revised to correct for such misstatements. Additionally, the Company will further present the revisions of its previously issued consolidated financial statements and relevant notes to the consolidated financial statements as of and for the year ended December 31, 2022 and prior in connection with the future filing of its 2023 Annual Report on Form 10-K.

Accounting Standards Adopted in

Accounting Standards Adopted in Current Year	9 Months Ended
	Sep. 30, 2023
Accounting Changes and Error Corrections [Abstract]
Accounting Standards Adopted in Current Year	2. Accounting Standards Adopted in Current Year There were no new accounting standards adopted during the nine months ended September 30, 2023 .

Leases

Leases	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Leases	3. Leases At September 30, 2023 and December 31, 2022, the Company’s lease assets and lease liabilities, primarily for its studios and corporate offices, were as follows: September 30, 2023 December 31, 2022 Assets: Operating leases $ 55,414 $ 75,696 Finance leases 10 54 Total lease assets $ 55,424 $ 75,750 Liabilities: Current Operating leases $ 9,804 $ 17,955 Finance leases 9 31 Noncurrent Operating leases 56,643 68,099 Finance leases 0 7 Total lease liabilities $ 66,456 $ 86,092 For the three and nine months ended September 30, 2023 and October 1, 2022, the components of the Company’s lease expense were as follows: Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Operating lease cost: Fixed lease cost $ 4,312 $ 9,071 $ 17,423 $ 24,974 Lease termination (benefit) cost ( 538 ) ( 189 ) 11,512 1,912 Variable lease cost 15 7 46 20 Total operating lease cost $ 3,789 $ 8,889 $ 28,981 $ 26,906 Finance lease cost: Amortization of leased assets 5 25 $ 43 $ 86 Interest on lease liabilities 0 4 1 6 Total finance lease cost $ 5 $ 29 $ 44 $ 92 Total lease cost $ 3,794 $ 8,918 $ 29,025 $ 26,998 As previously disclosed, in conjunction with the continued rationalization of its real estate portfolio, the Company entered into subleases with commencement dates in the first quarter of fiscal 2023. The Company recorded $ 931 and $ 2,455 of sublease income for the three and nine months ended September 30, 2023, respectively, as an offset to general and administrative expenses. At September 30, 2023 and December 31, 2022, the Company’s weighted average remaining lease term and weighted average discount rates were as follows: September 30, 2023 December 31, 2022 Weighted Average Remaining Lease Term (years) Operating leases 7.42 6.90 Finance leases 0.62 1.00 Weighted Average Discount Rate Operating leases 7.48 7.03 Finance leases 3.91 3.52 The Company’s leases have remaining lease term s of 0 to 9 years with a weighted average lease term of 7.42 years as of September 30, 2023. At September 30, 2023, the maturity of the Company’s lease liabilities in each of the next five fiscal years and thereafter were as follows: Operating Finance Total Remainder of fiscal 2023 $ 2,778 $ 2 $ 2,780 Fiscal 2024 15,307 7 15,314 Fiscal 2025 13,054 — 13,054 Fiscal 2026 10,056 — 10,056 Fiscal 2027 9,590 — 9,590 Fiscal 2028 9,277 — 9,277 Thereafter 26,919 — 26,919 Total lease payments $ 86,981 $ 9 $ 86,990 Less imputed interest 20,534 0 20,534 Present value of lease liabilities $ 66,447 $ 9 $ 66,456 Supplemental cash flow information related to leases for the nine months ended September 30, 2023 and October 1, 2022 were as follows: Nine Months Ended September 30, October 1, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 17,826 $ 24,244 Operating cash flows from finance leases $ 1 $ 6 Financing cash flows from finance leases $ 43 $ 86 Lease assets (modified) obtained in exchange for (modified) new operating lease liabilities $ ( 6,683 ) $ 11,160 Lease assets obtained in exchange for new finance lease liabilities $ — $ 44

Revenue

Revenue	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue	4. Revenue Revenues are recognized when control of the promised services or goods is transferred to the Company’s customers, in an amount that reflects the consideration it expects to be entitled to in exchange for those services or goods. The following table presents the Company’s revenues disaggregated by revenue source: Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Digital Subscription Revenues $ 140,889 $ 155,881 $ 437,613 $ 521,582 Workshops + Digital Fees 52,618 64,865 171,473 196,540 Clinical Subscription Revenues 9,989 — 17,581 — Subscription Revenues, net $ 203,496 $ 220,746 $ 626,667 $ 718,122 Product sales and other, net 11,375 28,972 56,927 98,810 Revenues, net $ 214,871 $ 249,718 $ 683,594 $ 816,932 Segment information for the three and nine months ended October 1, 2022 presented below has been updated to reflect the new reportable segment structure. The following tables present the Company’s revenues disaggregated by revenue source and segment: Three Months Ended September 30, 2023 North America International Total Digital Subscription Revenues $ 92,437 $ 48,452 $ 140,889 Workshops + Digital Fees 42,867 9,751 52,618 Clinical Subscription Revenues 9,989 — 9,989 Subscription Revenues, net $ 145,293 $ 58,203 $ 203,496 Product sales and other, net 9,394 1,981 11,375 Revenues, net $ 154,687 $ 60,184 $ 214,871 Three Months Ended October 1, 2022 North America International Total Digital Subscription Revenues $ 102,735 $ 53,146 $ 155,881 Workshops + Digital Fees 52,113 12,752 64,865 Subscription Revenues, net $ 154,848 $ 65,898 $ 220,746 Product sales and other, net 21,621 7,351 28,972 Revenues, net $ 176,469 $ 73,249 $ 249,718 Nine Months Ended September 30, 2023 North America International Total Digital Subscription Revenues $ 285,655 $ 151,958 $ 437,613 Workshops + Digital Fees 138,639 32,834 171,473 Clinical Subscription Revenues 17,581 — 17,581 Subscription Revenues, net $ 441,875 $ 184,792 $ 626,667 Product sales and other, net 46,025 10,902 56,927 Revenues, net $ 487,900 $ 195,694 $ 683,594 Nine Months Ended October 1, 2022 North America International Total Digital Subscription Revenues $ 342,489 $ 179,093 $ 521,582 Workshops + Digital Fees 155,558 40,982 196,540 Subscription Revenues, net $ 498,047 $ 220,075 $ 718,122 Product sales and other, net 71,478 27,332 98,810 Revenues, net $ 569,525 $ 247,407 $ 816,932 Information about Contract Balances For Subscription Revenues, the Company can collect payment in advance of providing services. Any amounts collected in advance of services being provided are recorded in deferred revenue. In the case where amounts are not collected, but the service has been provided and the revenue has been recognized, the amounts are recorded in accounts receivable. The opening and ending balances of the Company’s deferred revenues were as follows: Deferred Deferred Revenue Revenue-Long Term Balance as of December 31, 2022 $ 32,156 $ 360 Net increase (decrease) during the period 289 ( 155 ) Balance as of September 30, 2023 $ 32,445 $ 205 Balance as of January 1, 2022 $ 45,855 $ 28 Net (decrease) increase during the period ( 6,083 ) 11 Balance as of October 1, 2022 $ 39,772 $ 39 Revenue recognized from amounts included in current deferred revenue as of December 31, 2022 was $ 31,855 for the nine months ended September 30, 2023 . Revenue recognized from amounts included in current deferred revenue as of January 1, 2022 was $ 44,375 for the nine months ended October 1, 2022 . The Company’s long-term deferred revenue, which is included in other liabilities on the Company’s consolidated balance sheet, represents revenue that will not be recognized during the next 12 months and is generally related to upfront payments received as an inducement for entering into certain sales-based royalty agreements with third party licensees. This revenue is amortized on a straight-line basis over the term of the applicable agreement.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2023
Business Combinations [Abstract]
Acquisitions	5. Acquisitions Acquisition of Sequence On April 10, 2023 (the “Closing Date”), the Company completed its previously announced acquisition of Weekend Health, Inc., doing business as Sequence, a Delaware corporation (“Sequence”), subject to the terms and conditions set forth in the Agreement and Plan of Merger, dated as of March 4, 2023, by and among the Company, Well Holdings, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company, Sequence, and Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as the Equityholders’ Representative (as defined therein) for Sequence (the “Merger Agreement”), pursuant to which Sequence continued as a wholly-owned subsidiary of the Company (the “Acquisition”). Sequence provides a technology powered care platform and mobile web application through its subscription based service, which includes a comprehensive weight management program, pharmacotherapy treatment, nutrition plans, health insurance coordination services, and access to clinicians, dietitians, fitness coaches and care coordinators. As consideration for the Acquisition, the Company agreed to pay an aggregate amount equal to $ 132,000 , subject to the adjustments set forth in the Merger Agreement (the “Merger Consideration”). Subject to the terms and conditions of the Merger Agreement, the Merger Consideration has been paid, or is payable, as follows: (i) approximately $ 64,217 in cash (inclusive of approximately $ 25,800 of cash on the balance sheet of Sequence) and approximately $ 34,702 in the form of approximately 7,996 newly issued shares of Company common stock (valued at $ 4.34 per share), in each case, paid on or promptly following the Closing Date, (ii) $ 16,000 in cash to be paid on April 10, 2024, and (iii) $ 16,000 in cash to be paid on April 10, 2025, in each case, subject to the adjustments and deductions set forth in the Merger Agreement. The following table shows the purchase price allocation for Sequence to the acquired identifiable assets, liabilities assumed and goodwill: Total consideration: Cash paid at closing $ 64,217 Cash to be paid on April 10, 2024 16,000 Cash to be paid on April 10, 2025 (1) 12,420 Total cash payments $ 92,637 Less stock-based compensation expense attributable to post combination vesting ( 3,882 ) Common shares issued 7,996 Stock price as of April 10, 2023 (2) $ 4.12 Total stock issuance purchase price (2) 32,943 Aggregated merger consideration $ 121,698 Assets acquired: Cash $ 25,776 Prepaid expenses and other current assets 2,220 Property, plant and equipment 34 Intangible assets 7,768 Total assets acquired 35,798 Liabilities assumed: Accounts payable $ 70 Accrued liabilities 14 Deferred revenue 1,300 Deferred tax liability 1,906 Total liabilities assumed 3,290 Net assets acquired 32,508 Total goodwill $ 89,190 (1) Reflects $ 16,000 of cash payable on April 10, 2025 as Merger Consideration discounted using the Company's weighted average cost of debt. (2) Represents the fair value of the shares transferred to the sellers, based on the number of shares to be issued, 7,996 , multiplied by the closing price of the Company's ordinary shares on April 10, 2023 of $ 4.12 per share. The acquisition has been accounted for under the purchase method of accounting. The acquisition resulted in goodwill related to, among other things, expected synergies in operations. The goodwill will not be deductible for tax purposes. The results of operations of Sequence have been included in the consolidated operating results of the Company from the Closing Date. The Company incurred transaction-related costs of $ 0 and $ 8,605 for the three and nine months ended September 30, 2023, respectively. These costs were associated with legal and professional services and were recognized as operating expenses on the consolidated statements of operations. The Company’s consolidated statements of operations for the three and nine months ended September 30, 2023 included total revenue of $ 9,989 and $ 17,581 , respectively, and net loss of $ 3,133 and $ 4,763 , respectively, from Sequence. Acquisitions of Franchisees On February 18, 2022, the Company acquired the entire issued share capital of its Republic of Ireland franchisee, Denross Limited, and its Northern Ireland franchisee, Checkweight Limited, as follows: (a) The Company acquired the entire issued share capital of Denross Limited for a purchase price of $ 4,500 . Payment was in the form of cash paid on December 21, 2021 ($ 650 ), cash paid on February 18, 2022 ($ 3,100 ) and cash in reserves ($ 750 ), of which $ 375 was paid on February 17, 2023. The total purchase price was allocated to goodwill ($ 4,645 ), deferred tax asset ($ 496 ) fully offset by a tax valuation allowance ($ 496 ), assumed liabilities ($ 166 ), customer relationship value ($ 14 ), cash ($ 4 ) and other receivables ($ 3 ). The goodwill will not be deductible for tax purposes; and (b) The Company acquired the entire issued share capital of Checkweight Limited for a purchase price of $ 1,500 . Payment was in the form of cash ($ 1,250 ) and cash in reserves ($ 250 ), of which $ 125 was paid on February 17, 2023. The total purchase price was allocated to goodwill ($ 1,291 ), franchise rights acquired ($ 240 ), assumed liabilities ($ 56 ), customer relationship value ($ 17 ), deferred tax asset ($ 5 ) fully offset by a tax valuation allowance ($ 5 ), cash ($ 4 ) and other receivables ($ 4 ). The goodwill will not be deductible for tax purposes. These acquisitions have been accounted for under the purchase method of accounting and, accordingly, earnings of the acquired franchises have been included in the consolidated operating results of the Company since the date of acquisition.

Franchise Rights Acquired, Good

Franchise Rights Acquired, Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Franchise Rights Acquired, Goodwill and Other Intangible Assets	6. Franchise Rights Acquired, Goodwill and Other Intangible Assets Franchise rights acquired are due to acquisitions of the Company’s franchised territories as well as the acquisition of franchise promotion agreements and other factors associated with the acquired franchise territories. For the nine months ended September 30, 2023, the change in the carrying value of franchise rights acquired was due to the effect of exchange rate changes. Goodwill primarily relates to the acquisition of the Company by The Kraft Heinz Company (successor to H.J. Heinz Company) in 1978, and the Company’s acquisitions of WW.com, LLC (formerly known as WW.com, Inc. and WeightWatchers.com, Inc.) in 2005, Sequence in 2023 and the Company’s franchised territories. See Note 5 for additional information about acquisitions by the Company. For the nine months ended September 30, 2023, the change in the carrying amount of goodwill was due to the acquisition of Sequence and the effect of exchange rate changes as follows: North America International Total Balance as of January 1, 2022 $ 147,530 $ 9,844 $ 157,374 Goodwill acquired during the period — 5,936 5,936 Goodwill impairment ( 1,101 ) ( 2,023 ) ( 3,124 ) Effect of exchange rate changes ( 2,862 ) ( 1,326 ) ( 4,188 ) Balance as of December 31, 2022 $ 143,567 $ 12,431 $ 155,998 Goodwill acquired during the period 89,190 — 89,190 Effect of exchange rate changes ( 6 ) ( 255 ) ( 261 ) Balance as of September 30, 2023 $ 232,751 $ 12,176 $ 244,927 Franchise Rights Acquired Finite-lived franchise rights acquired are amortized over the remaining contractual period, which is generally less than one year . Indefinite-lived franchise rights acquired are tested for potential impairment on at least an annual basis or more often if events so require. In performing the impairment analysis for indefinite-lived franchise rights acquired, the fair value for franchise rights acquired is estimated using a discounted cash flow approach referred to as the hypothetical start-up approach for franchise rights related to the Company’s Workshops + Digital business and a relief from royalty methodology for franchise rights related to the Company’s Digital business. The aggregate estimated fair value for these franchise rights is then compared to the carrying value of the unit of account for these rights. The Company has determined the appropriate unit of account for purposes of assessing impairment to be the combination of the rights in both the Workshops + Digital business and the Digital business in the country in which the applicable acquisition occurred. The net book values of these franchise rights in the United States, Australia, United Kingdom and New Zealand as of the September 30, 2023 balance sheet date were $ 374,354 , $ 3,995 , $ 2,688 and $ 2,295 , respectively. In its hypothetical start-up approach analysis for fiscal 2023, the Company assumed that the year of maturity was reached after 7 years. Subsequent to the year of maturity, the Company estimated future cash flows for the Workshops + Digital business in each country based on assumptions regarding revenue growth and operating income margins. In the Company’s relief from royalty approach analysis for fiscal 2023, the cash flows associated with the Digital business in each country were based on the expected Digital revenue for such country and the application of a royalty rate based on current market terms. The cash flows for the Workshops + Digital and the Digital businesses were discounted utilizing rates which were calculated using the weighted-average cost of capital, which included the cost of equity and the cost of debt. Goodwill In performing the impairment analysis for goodwill, the fair value for the Company’s reporting units is estimated using a discounted cash flow approach. This approach involves projecting future cash flows attributable to the reporting unit and discounting those estimated cash flows using an appropriate discount rate. The estimated fair value is then compared to the carrying value of the reporting unit. Excluding the goodwill associated with the acquisition of Sequence, the Company has determined the appropriate reporting unit for purposes of assessing annual impairment to be the country for all reporting units. The net book values of goodwill, excluding the acquisition of Sequence, in the United States, Canada and other countries as of the September 30, 2023 balance sheet date were $ 104,020 , $ 39,541 and $ 12,176 , respectively. In performing the impairment analysis for goodwill, for all of the Company’s reporting units, the Company estimated future cash flows by utilizing the historical debt-free cash flows (cash flows provided by operations less capital expenditures) attributable to that country and then applied expected future operating income growth rates for such country. The Company utilized operating income as the basis for measuring its potential growth because it believes it is the best indicator of the performance of its business. The Company then discounted the estimated future cash flows utilizing a discount rate which was calculated using the weighted-average cost of capital, which included the cost of equity and the cost of debt. Indefinite-Lived Franchise Rights Acquired and Goodwill Annual Impairment Tests The Company reviews indefinite-lived intangible assets, including franchise rights acquired with indefinite lives, and goodwill for potential impairment on at least an annual basis or more often if events so require. The Company performed its annual fair value impairment testing as of May 7, 2023 and May 8, 2022, each the first day of fiscal May, on its indefinite-lived intangible assets and goodwill. In performing its annual impairment analysis as of May 7, 2023, the Company determined that the carrying amounts of its franchise rights acquired with indefinite-lived units of account and goodwill reporting units did not exceed their respective fair values and, therefore, no impairment existed. In perf orming its annual impairment analysis as of May 8, 2022, the Company determined that (i) the carrying amounts of its Canada and New Zealand franchise rights acquired with indefinite-lived units of account exceeded their respective fair values and, as a result, the Company recorded impairment charges for its Canada and New Zealand units of account of $ 24,485 and $ 834 , respectively, in the second quarter of fiscal 2022; and (ii) the carrying amounts of all of its other franchise rights acquired with indefinite-lived units of account did not exceed their respective fair values and, therefore, no impairment existed with respect thereto. In performing its annual impairment analysis as of May 8, 2022, the Company determined that the carrying amounts of its goodwill reporting units did not exceed their respective fair values and, therefore, no impairment existed. Based on the results of the Company’s May 7, 2023 annual franchise rights acquired impairment analysis performed for all of its units of account, all units, except for New Zealand, had an estimated fair value at least 70 % higher than the respective unit’s carrying amount. Collectively, these units of account represented 99.4 % of the Company’s franchise rights acquired as of the September 30, 2023 balance sheet date. Based on the results of the Company’s May 7, 2023 annual franchise rights acquired impairment analysis performed for its New Zealand unit of account, which held 0.6 % of the Company’s franchise rights acquired as of the September 30, 2023 balance sheet date, the estimated fair value of this unit of account exceeded its carrying value by approximately 20 %. Accordingly, a change in the underlying assumptions for the New Zealand unit of account may change the results of the impairment assessment and, as such, could result in an impairment of the franchise rights acquired related to New Zealand, for which the net book value was $ 2,295 as of September 30, 2023. In performing the annual franchise rights acquired impairment analysis for fiscal 2023, in the Company’s hypothetical start-up approach analysis, for the year of maturity, it assumed Workshops + Digital revenue (comprised of Workshops + Digital Fees and revenues from products sold to members in studios) growth of ( 37.1 %) to ( 18.4 %) in the year of maturity from fiscal 2022, in each case, earned in the applicable country, and assumed cumulative annual revenue growth rates for the years beyond the year of maturity of 2.8 %. For the year of maturity and beyond, the Company assumed operating income margin rates of ( 6.4 %) to 12.7 %. I n the Company’s relief from royalty approach, it assumed Digital revenue growth in each country of ( 14.8 %) to 7.5 % for fiscal 2023. Based on the results of the Company’s May 7, 2023 annual goodwill impairment analysis performed for all of its reporting units, all units, except for the Republic of Ireland, had an estimated fair value at least 120 % higher than the respective unit’s carrying amount. Collectively, these reporting units represented 99.1 % of the Company’s goodwill as of the September 30, 2023 balance sheet date. Based on the results of the Company’s May 7, 2023 annual goodwill impairment analysis performed for its Republic of Ireland reporting unit, which held 0.9 % of the Company’s goodwill as of the September 30, 2023 balance sheet date, the estimated fair value of this reporting unit exceeded its carrying value by approximately 55 %. Accordingly, a change in the underlying assumptions for the Republic of Ireland may change the results of the impairment assessment and, as such, could result in an impairment of the goodwill related to the Republic of Ireland, for which the net book value was $ 2,307 as of September 30, 2023. The following are the more significant assumptions utilized in the Company's annual goodwill impairment analyses for fiscal 2023 and fiscal 2022: Fiscal 2023 Fiscal 2022 Debt-Free Cumulative Annual Cash Flow Growth Rate 3.9 % to 24.9 % 1.2 % to 20.6 % Discount Rate 10.8 % 9.6 % Indefinite-Lived Franchise Rights Acquired Interim Impairment Test During the quarter ended October 1, 2022, the Company identified various qualitative and quantitative factors which collectively, when combined with the difference or lack thereof between the estimated fair value of the applicable unit of account and its carrying value for the United States, Canada and New Zealand units of account, indicated a triggering event had occurred within these units of account. These factors included actual business performance as compared to the assumptions used in its annual impairment test, the continued decline in the Company’s market capitalization and market factors, including the increase in interest rates. As a result of this triggering event, the Company performed an interim impairment test of these units of account. In performing this interim impairment test as of October 1, 2022, the Company determined that the carrying amounts of its United States, Canada and New Zealand franchise rights acquired with indefinite-lived units of account exceeded their respective fair values. Accordingly, the Company recorded impairment charges for its United States, Canada and New Zealand units of account of $ 298,291 , $ 13,312 and $ 1,138 , respectively, in the third quarter of fiscal 2022. The preponderance of these impairments was driven by the increased weighted-average cost of capital used in this interim impairment test as compared to the weighted-average cost of capital used in the May 8, 2022 annual impairment test of its indefinite-lived franchise rights acquired, reflecting market factors including higher interest rates and the trading values of the Company's equity and debt. Kurbo Goodwill Impairment On August 10, 2018, the Company acquired substantially all of the assets of Kurbo Health, Inc., a family-based healthy lifestyle coaching program, for a net purchase price of $ 3,063 , of which $ 1,101 was allocated to goodwill. The goodwill was deductible annually for tax purposes. The Company determined in the second quarter of fiscal 2022 to exit the Kurbo business in the third quarter of fiscal 2022 as part of its strategic plan. As a result of this determination, the Company recorded an impairment charge of $ 1,101 in the second quarter of fiscal 2022, which comprised the entire goodwill balance for Kurbo. Finite-lived Intangible Assets The carrying values of finite-lived intangible assets as of September 30, 2023 and December 31, 2022 were as follows: September 30, 2023 December 31, 2022 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Capitalized software costs $ 109,250 $ 101,753 $ 107,229 $ 94,375 Website development costs 164,975 113,570 133,818 91,482 Trademarks 12,177 12,003 12,162 11,882 Other 13,949 6,493 13,961 6,125 Trademarks and other intangible assets $ 300,351 $ 233,819 $ 267,170 $ 203,864 Franchise rights acquired 8,209 5,373 8,164 5,101 Total finite-lived intangible assets $ 308,560 $ 239,192 $ 275,334 $ 208,965 Aggregate amortization expense for finite-lived intangible assets was recorded in the amounts of $ 13,628 and $ 32,590 for the three and nine months ended September 30, 2023, respectively. Aggregate amortization expense for finite-lived intangible assets was recorded in the amounts of $ 8,347 and $ 25,282 for the three and nine months ended October 1, 2022, respectively. Estimated amortization expense of existing finite-lived intangible assets for the next five fiscal years and thereafter is as follows: Remainder of fiscal 2023 $ 10,937 Fiscal 2024 $ 27,292 Fiscal 2025 $ 17,679 Fiscal 2026 $ 5,500 Fiscal 2027 $ 725 Fiscal 2028 $ 533 Thereafter $ 6,702

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Long-Term Debt	7. Long-Term Debt The components of the Company’s long-term debt were as follows: September 30, 2023 December 31, 2022 Principal Unamortized Unamortized Effective (1) Principal Unamortized Unamortized Effective (1) Revolving Credit Facility due $ — $ — $ — 0.00 % $ — $ — $ — 0.00 % Term Loan Facility due 945,000 4,989 10,340 8.99 % 945,000 5,821 12,064 5.85 % Senior Secured Notes due 500,000 4,252 — 4.65 % 500,000 4,831 — 4.70 % Total $ 1,445,000 $ 9,241 $ 10,340 7.48 % $ 1,445,000 $ 10,652 $ 12,064 5.45 % Less: Current portion — — Unamortized deferred 9,241 10,652 Unamortized debt discount 10,340 12,064 Total long-term debt $ 1,425,419 $ 1,422,284 (1) Includes amortization of deferred financing costs and debt discount. On April 13, 2021, the Company (1) repaid in full approximately $ 1,189,750 in aggregate principal amount of senior secured tranche B term loans due in 2024 under its then-existing credit facilities and (2) redeemed all of the $ 300,000 in aggregate principal amount of its then-outstanding 8.625 % Senior Notes due in 2025 (the “Discharged Senior Notes”). On April 13, 2021, the Company’s then-existing credit facilities included a senior secured revolving credit facility (which included borrowing capacity available for letters of credit) due in 2022 with $ 175,000 in an aggregate principal amount of commitments. There were no outstanding borrowings under such revolving credit facility on that date. The Company funded such repayment of loans and redemption of notes with cash on hand as well as with proceeds received from approximately $ 1,000,000 in an aggregate principal amount of borrowings under its new credit facilities (as amended from time to time, the “Credit Facilities”) and proceeds received from the issuance of $ 500,000 in aggregate principal amount of 4.500 % Senior Secured Notes due 2029 (the “Senior Secured Notes”), each as described below. These transactions are collectively referred to herein as the “April 2021 debt refinancing”. During the second quarter of fiscal 2021, the Company incurred fees of $ 37,910 (which included $ 12,939 of a prepayment penalty on the Discharged Senior Notes and $ 5,000 of a debt discount on its Term Loan Facility (as defined below)) in connection with the April 2021 debt refinancing. In addition, the Company recorded a loss on early extinguishment of debt of $ 29,169 in connection thereto. This early extinguishment of debt charge was comprised of $ 12,939 of a prepayment penalty on the Discharged Senior Notes, $ 9,017 of financing fees paid in connection with the April 2021 debt refinancing and the write-off of $ 7,213 of pre-existing deferred financing fees and debt discount. Credit Facilities The Credit Facilities were issued under a credit agreement, dated April 13, 2021 (as amended from time to time, the “Credit Agreement”), among the Company, as borrower, the lenders party thereto, and Bank of America, N.A. (“Bank of America”), as administrative agent and an issuing bank. The Credit Facilities consist of (1) $ 1,000,000 in aggregate principal amount of senior secured tranche B term loans due in 2028 (the “Term Loan Facility”) and (2) $ 175,000 in an aggregate principal amount of commitments under a senior secured revolving credit facility (which includes borrowing capacity available for letters of credit) due in 2026 (the “Revolving Credit Facility”). In December 2021, the Company made voluntary prepayments at par in an aggregate amount of $ 52,500 in respect of its outstanding term loans under the Term Loan Facility. As a result of these prepayments, the Company wrote off a debt discount and deferred financing fees of $ 1,183 in the aggregate in the fourth quarter of fiscal 2021. As of September 30, 2023, the Company had $ 945,000 in an aggregate principal amount of loans outstanding under the Credit Facilities, w ith $ 173,921 of availability and $ 1,079 in issued but undrawn letters of credit outstanding under the Revolving Credit Facility subject to its terms and conditions as discussed below. There were no outst anding borrowings under the Revolving Credit Facility as of September 30, 2023. All obligations under the Credit Agreement are guaranteed by, subject to certain exceptions, each of the Company’s current and future wholly-owned material domestic restricted subsidiaries. All obligations under the Credit Agreement, and the guarantees of those obligations, are secured by substantially all of the assets of the Company and each guarantor, subject to customary exceptions, including: • a pledge of 100 % of the equity interests directly held by the Company and each guarantor in any wholly-owned material subsidiary of the Company or any guarantor (which pledge, in the case of any non-U.S. subsidiary of a U.S. subsidiary, will not include more than 65 % of the voting stock of such first-tier non-U.S. subsidiary), subject to certain exceptions; and • a security interest in substantially all other tangible and intangible assets of the Company and each guarantor, subject to certain exceptions. The Credit Facilities require the Company to prepay outstanding term loans, subject to certain exceptions, with: • 50 % (which percentage will be reduced to 25 % and 0 % if the Company attains certain first lien secured net leverage ratios) of the Company’s annual excess cash flow; • 100 % of the net cash proceeds of certain non-ordinary course asset sales by the Company and its restricted subsidiaries (including casualty and condemnation events, subject to de minimis thresholds), and subject to the right to reinvest 100 % of such proceeds, subject to certain qualifications; and • 100 % of the net proceeds of any issuance or incurrence of debt by the Company or any of its restricted subsidiaries, other than certain debt permitted under the Credit Agreement. The foregoing mandatory prepayments will be used to reduce the installments of principal on the Term Loan Facility. The Company may voluntarily repay outstanding loans under the Credit Facilities at any time without penalty, except for customary “breakage” costs with respect to Term SOFR loans under the Credit Facilities. In June 2023, in connection with the planned phase-out of LIBOR, the Company amended its Credit Facilities to replace LIBOR with Term SOFR as the benchmark rate under the Credit Agreement, which will be calculated to include a credit spread adjustment of 0.11448 %, 0.26161 %, 0.42826 %, or 0.71513 % for 1, 3, 6, or 12 months period, respectively, in addition to the Term SOFR Screen Rate (as defined in the Credit Agreement) and the margin (which was not amended). Borrowings under the Term Loan Facility bear interest at a rate per annum equal to, at the Company’s option, either (1) an applicable margin plus a base rate determined by reference to the highest of (a) 0.50 % per annum plus the Federal Funds Effective Rate as determined by the Federal Reserve Bank of New York, (b) the prime rate of Bank of America and (c) the Term SOFR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month adjusted for certain additional costs, plus 1.00 %; provided that such rate is not lower than a floor of 1.50 % or (2) an applicable margin plus a Term SOFR rate determined by reference to the cost of funds for U.S. dollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs, provided that Term SOFR is not lower than a floor of 0.50 %. Borrowings under the Revolving Credit Facility bear interest at a rate per annum equal to an applicable margin based upon a leverage-based pricing grid, plus, at the Company’s option, either (1) a base rate determined by reference to the highest of (a) 0.50 % per annum plus the Federal Funds Effective Rate as determined by the Federal Reserve Bank of New York, (b) the prime rate of Bank of America and (c) the Term SOFR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month adjusted for certain additional costs, plus 1.00 %; provided that such rate is not lower than a floor of 1.00 % or (2) a Term SOFR rate determined by reference to the cost of funds for U.S. dollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs, provided such rate is not lower than a floor of zero . As of September 30, 2023, the applicable margins for the Term SOFR rate borrowings under the Term Loan Facility and the Revolving Credit Facility were 3.50 % and 2.75 %, res pectively. On a quarterly basis, the Company pays a commitment fee to the lenders under the Revolving Credit Facility in respect of unutilized commitments thereunder, which commitment fee fluctuates depending upon the Company’s Consolidated First Lien Leverage Ratio (as defined in the Credit Agreement). The Credit Agreement contains other customary terms, including (1) representations, warranties and affirmative covenants, (2) negative covenants, including limitations on indebtedness, liens, mergers, acquisitions, asset sales, investments, distributions, prepayments of subordinated debt, amendments of material agreements governing subordinated indebtedness, changes to lines of business and transactions with affiliates, in each case subject to baskets, thresholds and other exceptions, and (3) customary events of default. The availability of certain baskets and the ability to enter into certain transactions are also subject to compliance with certain financial ratios. In addition, if the aggregate principal amount of extensions of credit outstanding under the Revolving Credit Facility as of any fiscal quarter end exceeds 35 % of the amount of the aggregate commitments under the Revolving Credit Facility in effect on such date, the Company must be in compliance with a Consolidated First Lien Leverage Ratio of 5.50 :1.00 for the period ending after the first fiscal quarter of 2023 through and including the first fiscal quarter of 2024, with a step down to 5.25 :1.00 for the period ending after the first fiscal quarter of 2024 through and including the first fiscal quarter of 2025, and an additional step down to 5.00 :1.00 for the period following the first fiscal quarter of 2025. As of September 30, 2023, the Company’s actual Consolidated First Lien Leverage Ratio was 8.64 : 1.00 and there were no borrowings under its Revolving Credit Facility and total letters of credit issued were $ 1,079 . The Company was not in compliance with the Consolidated First Lien Leverage Ratio as of September 30, 2023 , and as a result, the Company is limited to borrowing no more than 35 %, or $ 61,250 , of the amount of the aggregate commitments under the Revolving Credit Facility as of each fiscal quarter end until the Company complies with the applicable ratio. Senior Secured Notes The Senior Secured Notes were issued pursuant to an Indenture, dated as of April 13, 2021 (as amended, supplemented or modified from time to time, the “Indenture”), among the Company, the guarantors named therein and The Bank of New York Mellon, as trustee and notes collateral agent. The Indenture contains customary terms, events of default and covenants for an issuer of non-investment grade debt securities. These covenants include limitations on indebtedness, liens, mergers, acquisitions, asset sales, investments, distributions, prepayments of subordinated debt and transactions with affiliates, in each case subject to baskets, thresholds and other exceptions. The Senior Secured Notes accrue interest at a rate per annum equal to 4.500 % and will mature on April 15, 2029 . Interest on the Senior Secured Notes is payable semi-annually on April 15 and October 15 of each year, beginning on October 15, 2021. On or after April 15, 2024 , the Company may on any one or more occasions redeem some or all of the Senior Secured Notes at a purchase price equal to 102.250 % of the principal amount of the Senior Secured Notes, plus accrued and unpaid interest, if any, to, but not including, the redemption date, such optional redemption price decreasing to 101.125 % on or after April 15, 2025 and to 100.000 % on or after April 15, 2026 . Prior to April 15, 2024, the Company may on any one or more occasions redeem up to 40 % of the aggregate principal amount of the Senior Secured Notes with an amount not to exceed the net proceeds of certain equity offerings at 104.500 % of the aggregate principal amount thereof, plus accrued and unpaid interest, if any, to, but not including, the redemption date. Prior to April 15, 2024, the Company may redeem some or all of the Senior Secured Notes at a make-whole price plus accrued and unpaid interest, if any, to, but not including, the redemption date. In addition, during any twelve-month period ending prior to April 15, 2024, the Company may redeem up to 10 % of the aggregate principal amount of the Senior Secured Notes at a purchase price equal to 103.000 % of the principal amount of the Senior Secured Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. If a change of control occurs, the Company must offer to purchase for cash the Senior Secured Notes at a purchase price equal to 101 % of the principal amount of the Senior Secured Notes, plus accrued and unpaid interest, if any, to, but not including, the purchase date. Following the sale of certain assets and subject to certain conditions, the Company must offer to purchase for cash the Senior Secured Notes at a purchase price equal to 100 % of the principal amount of the Senior Secured Notes, plus accrued and unpaid interest, if any, to, but not including, the purchase date. The Senior Secured Notes are guaranteed on a senior secured basis by the Company’s subsidiaries that guarantee the Credit Facilities. The Senior Secured Notes and the note guarantees are secured by a first-priority lien on all the collateral that secures the Credit Facilities, subject to a shared lien of equal priority with the Company’s and each guarantor’s obligations under the Credit Facilities and subject to certain thresholds, exceptions and permitted liens. Outstanding Debt At September 30, 2023 , the Company had $ 1,445,000 outstanding under the Credit Facilities and the Senior Secured Notes, consisting of borrowings under the Term Loan Facility of $ 945,000 , $ 0 drawn down on the Revolving Credit Facility and $ 500,000 in aggregate principal amount of Senior Secured Notes issued and outstanding. At September 30, 2023 and December 31, 2022, the Company’s debt consisted of both fixed and variable-rate instruments. Interest rate swaps were entered into to hedge a portion of the cash flow exposure associated with the Company’s variable-rate borrowings. See Note 11 for information on the Company’s interest rate swaps. The weighted average interest rate (which includes amortization of deferred financing costs and debt discount) on the Company’s outstanding debt, exclusive of the impact of the swaps then in effect, was approximately 7.48 % and 5.45 % per annum at September 30, 2023 and December 31, 2022, respectively, based on interest rates on these dates. The weighted average interest rate (which includes amortization of deferred financing costs and debt discount) on the Company’s outstanding debt, including the impact of the swaps then in effect, was approximately 6.44 % and 5.50 % per annum at September 30, 2023 and December 31, 2022, respectively, based on interest rates on these dates.

Per Share Data

Per Share Data	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Per Share Data	8. Per Share Data Basic earnings (net loss) per share is calculated utilizing the weighted average number of common shares outstanding during the periods presented. Diluted earnings (net loss) per share is calculated utilizing the weighted average number of common shares outstanding during the periods presented adjusted for the effect of dilutive common stock equivalents. The following table sets forth the computation of basic and diluted earnings (net loss) per share: Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Numerator: Net income (loss) $ 43,731 $ ( 206,036 ) $ ( 24,120 ) $ ( 221,087 ) Denominator: Weighted average shares of common stock outstanding 78,979 70,383 75,861 70,258 Effect of dilutive common stock equivalents 1,659 — — — Weighted average diluted common shares outstanding 80,638 70,383 75,861 70,258 Earnings (net loss) per share Basic $ 0.55 $ ( 2.93 ) $ ( 0.32 ) $ ( 3.15 ) Diluted $ 0.54 $ ( 2.93 ) $ ( 0.32 ) $ ( 3.15 ) The number of anti-dilutive common stock equivalents excluded from the calculation of the weighted average number of common shares for diluted earnings (net loss) per share was 6,770 and 9,229 for the three months ended September 30, 2023 and October 1, 2022 , respectively. The number of anti-dilutive common stock equivalents excluded from the calculation of the weighted average number of common shares for diluted net loss per share was 9,341 and 8,307 for the nine months ended September 30, 2023 and October 1, 2022 , respectively.

Taxes

Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Taxes	9. Taxes Income Taxes The Company’s effective tax rates for the three and nine months ended September 30, 2023 were ( 727.7 %) and 44.0 % , respectively, compared to 25.6 % and 24.9 % for the three and nine months ended October 1, 2022 , respectively. The effective tax rate for interim periods is determined using an annual effective tax rate, adjusted for discrete items. In fiscal 2023, the Company was required to increase the valuation allowance recorded against U.S. deferred tax assets as a result of the limitation on interest deductions in the U.S. The forecasted full-year tax expense, which included the increase in valuation allowance, in relation to the Company’s forecasted full-year pretax loss (albeit minimal), drove an unusually high negative annual effective tax rate, resulting in an income tax benefit of $ 18,933 for the nine months ended September 30, 2023 . This tax benefit resulted in an income tax benefit of $ 38,447 for the three months ended September 30, 2023, since an income tax expense of $ 19,515 was recorded for the six months ended July 1, 2023. For the nine months ended September 30, 2023, the difference between the U.S. federal statutory tax rate and the Company’s consolidated effective tax rate was primarily due to the valuation allowance noted above. In addition, the effective tax rate was impacted by tax expense from income earned in foreign jurisdictions, partially offset by a tax benefit related to foreign-derived intangible income (“FDII”). For the nine months ended October 1, 2022, the tax benefit was impacted by a U.S. state tax rate change, partially offset by tax shortfalls from stock compensation. For the nine months ended October 1, 2022, the difference between the U.S. federal statutory tax rate and the Company’s consolidated effective tax rate was primarily due to state income tax expense and tax expense from income earned in foreign jurisdictions, partially offset by a tax benefit related to FDII. Non-Income Tax Matters The Internal Revenue Service (the “IRS”) notified the Company of certain penalties assessed related to the annual disclosure and reporting requirements of the Affordable Care Act. The Company is in the process of appealing this determination and does not believe it has any liability with respect to this matter. Until the appeals process is complete, the IRS will maintain a federal tax lien which is currently limited to certain IRS refunds due to the Company.

Legal

Legal	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Legal	10. Legal Due to the nature of the Company’s activities, it is, at times, subject to pending and threatened legal actions that arise out of the ordinary course of business. In the opinion of management, the disposition of any such matters is not expected, individually or in the aggregate, to have a material adverse effect on the Company’s results of operations, financial condition or cash flows. However, the results of legal actions cannot be predicted with certainty. Therefore, it is possible that the Company’s results of operations, financial condition or cash flows could be materially adversely affected in any particular period by the unfavorable resolution of one or more legal actions.

Derivative Instruments and Hedg

Derivative Instruments and Hedging	9 Months Ended
	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging	11. Derivative Instruments and Hedging In June 2023, the Company amended the terms of its interest rate swap agreements to implement a forward-looking interest rate based on Term SOFR in place of LIBOR. Since the interest rate swap agreements were affected by reference rate reform, the Company applied the expedients and exceptions provided to preserve the past presentation of its derivatives without de-designating the existing hedging relationships. All amendments to interest rate swap agreements were executed with the existing counterparties and did not change the notional amounts, maturity dates, or other critical terms of the hedging relationships. As of September 30, 2023 and December 31, 2022, the Company had in effect interest rate swaps with an aggregate notional amount totaling $ 500,000 . On June 11, 2018, in order to hedge a portion of its variable rate debt, the Company entered into a forward-starting interest rate swap (the “2018 swap”) with an effective date of April 2, 2020 and a termination date of March 31, 2024 . The initial notional amount of this swap was $ 500,000 . During the term of this swap, the notional amount decreased from $ 500,000 effective April 2, 2020 to $ 250,000 on March 31, 2021 . This interest rate swap effectively fixed the variable interest rate on the notional amount of this swap at 3.1513 %. On June 7, 2019, in order to hedge a portion of its variable rate debt, the Company entered into a forward-starting interest rate swap (the “2019 swap”, and together with the 2018 swap, the “current swaps”) with an effective date of April 2, 2020 and a termination date of March 31, 2024 . The notional amount of this swap is $ 250,000 . This interest rate swap effectively fixed the variable interest rate on the notional amount of this swap at 1.9645 %. The current swaps qualify for hedge accounting and, therefore, changes in the fair value of the current swaps have been recorded in accumulated other comprehensive loss. As of September 30, 2023, the cumulative unrealized gain for qualifying hedges was reported as a component of accumulated other comprehensive loss in the amount of $ 5,507 ($ 7,192 before taxes). As of December 31, 2022, the cumulative unrealized gain for qualifying hedges was reported as a component of accumulated other comprehensive loss in the amount of $ 10,723 ($ 14,146 before taxes). The following table presents the aggregate fair value of the Company’s derivative financial instruments by balance sheet classification and location: Fair Value Balance Sheet Classification Balance Sheet September 30, 2023 December 31, 2022 Assets: Interest rate swaps - current swaps Current asset Prepaid expenses and other current assets $ 7,272 $ 11,748 Interest rate swaps - current swaps Noncurrent asset Other noncurrent assets — 2,450 Total assets $ 7,272 $ 14,198 The Company is hedging forecasted transactions for periods not exceeding the next year . The Company expects approximately $ 7,926 ($ 10,569 before taxes) of net derivative gains included in accumulated other comprehensive loss at September 30, 2023 , based on current market rates, will be reclassified into earnings within the next 12 months.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	12. Fair Value Measurements Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: • Level 1 – Quoted prices in active markets for identical assets or liabilities. • Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. When measuring fair value, the Company is required to maximize the use of observable inputs and minimize the use of unobservable inputs. Fair Value of Financial Instruments The Company’s significant financial instruments include long-term debt and interest rate swap agreements as of September 30, 2023 and December 31, 2022. Since there were no outstanding borrowings under the Revolving Credit Facility as of September 30, 2023 and December 31, 2022, the fair value approximated a carrying value of $ 0 at both September 30, 2023 and December 31, 2022. The fair value of the Company’s Credit Facilities is determined by utilizing average bid prices on or near the end of each fiscal quarter (Level 2 input). As of September 30, 2023 and December 31, 2022, the fair value of the Company’s long-term debt was approximately $ 1,058,128 and $ 782,384 , respectively, as compared to the carrying value (net of deferred financing costs and debt discount) of $ 1,425,419 and $ 1,422,284 , respectively. Derivative Financial Instruments The fair values for the Company’s derivative financial instruments are determined using observable current market information such as the prevailing Term SOFR interest rate and Term SOFR yield curve rates and include consideration of counterparty credit risk. See Note 11 for disclosures related to derivative financial instruments. The following table presents the aggregate fair value of the Company’s derivative financial instruments: Fair Value Measurements Using: Total Quoted Prices in Significant Other Significant Interest rate swap current asset at September 30, 2023 $ 7,272 $ — $ 7,272 $ — Interest rate swap current asset at December 31, 2022 $ 11,748 $ — $ 11,748 $ — Interest rate swap noncurrent asset at December 31, 2022 $ 2,450 $ — $ 2,450 $ — The Company did no t have any transfers into or out of Levels 1 and 2 and did not maintain any assets or liabilities classified as Level 3 during the nine months ended September 30, 2023 and the fiscal year ended December 31, 2022.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Accumulated Other Comprehensive Loss	13. Accumulated Other Comprehensive Loss Amounts reclassified out of accumulated other comprehensive loss were as follows: Changes in Accumulated Other Comprehensive Loss by Component (1) Nine Months Ended September 30, 2023 Gain on Loss on Total Beginning balance at December 31, 2022 $ 10,723 $ ( 16,193 ) $ ( 5,470 ) Other comprehensive income (loss) before reclassifications, net of tax 1,778 ( 1,282 ) 496 Amounts reclassified from accumulated other comprehensive loss, net of tax (2) ( 6,994 ) — ( 6,994 ) Net current period other comprehensive loss $ ( 5,216 ) $ ( 1,282 ) $ ( 6,498 ) Ending balance at September 30, 2023 $ 5,507 $ ( 17,475 ) $ ( 11,968 ) (1) Amounts in parentheses indicate debits (2) See separate table below for details about these reclassifications Nine Months Ended October 1, 2022 (Loss) Gain on Loss on Total Beginning balance at January 1, 2022 $ ( 10,843 ) $ ( 7,761 ) $ ( 18,604 ) Other comprehensive income (loss) before reclassifications, net of tax 17,350 ( 13,488 ) 3,862 Amounts reclassified from accumulated other comprehensive loss, net of tax (2) 3,425 — 3,425 Net current period other comprehensive income (loss) $ 20,775 $ ( 13,488 ) $ 7,287 Ending balance at October 1, 2022 $ 9,932 $ ( 21,249 ) $ ( 11,317 ) (1) Amounts in parentheses indicate debits (2) See separate table below for details about these reclassifications Reclassifications out of Accumulated Other Comprehensive Loss (1) Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Details about Other Comprehensive Amounts Reclassified from Amounts Reclassified from Affected Line Item in the Gain (Loss) on Qualifying Hedges Interest rate contracts $ 3,559 $ ( 326 ) $ 9,327 $ ( 4,575 ) Interest expense 3,559 ( 326 ) 9,327 ( 4,575 ) Income (loss) before income taxes ( 890 ) 82 ( 2,333 ) 1,150 Benefit from income taxes $ 2,669 $ ( 244 ) $ 6,994 $ ( 3,425 ) Net income (loss) (1) Amounts in parentheses indicate debits to profit/loss

Segment Data

Segment Data	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Segment Data	14. Segment Data As previously disclosed, effective the first day of fiscal 2023 (i.e., January 1, 2023), the Company realigned its organizational structure and resources to more closely align with its strategic priorities and centralized the global management of certain functions and systems. As a result of the change in its organizational structure, the Company now has two reportable segments, consisting of North America and International, for the purpose of making operational and resource decisions and assessing financial performance. “North America” refers to the Company’s North American Company-owned operations and franchise revenues and related costs; and “International” refers to the Company’s Continental Europe Company-owned operations, United Kingdom Company-owned operations, and Australia, New Zealand and emerging markets operations. The new reportable segments will continue to provide similar services and products. To be consistent with the information that is presented to the chief operating decision maker, the Company does not include intercompany activity in the segment results. Segment information for the three and nine months ended October 1, 2022 presented below has been updated to reflect the new reportable segment structure. Information about the Company’s reportable segments is as follows: Total Revenues, net Total Revenues, net Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 North America $ 154,687 $ 176,469 $ 487,900 $ 569,525 International 60,184 73,249 195,694 247,407 Total revenues, net $ 214,871 $ 249,718 $ 683,594 $ 816,932 Net Income (Loss) Net Loss Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Segment operating income (loss): North America $ 36,064 $ ( 255,102 ) $ 81,850 $ ( 207,039 ) International 23,675 29,074 55,797 77,216 Total segment operating income (loss) 59,739 ( 226,028 ) 137,647 ( 129,823 ) General corporate expenses 29,132 28,501 109,307 102,370 Interest expense 24,508 20,912 71,429 58,837 Other expense (income), net 815 1,344 ( 36 ) 3,303 Benefit from income taxes ( 38,447 ) ( 70,749 ) ( 18,933 ) ( 73,246 ) Net income (loss) $ 43,731 $ ( 206,036 ) $ ( 24,120 ) $ ( 221,087 ) Depreciation and Amortization Depreciation and Amortization Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 North America $ 8,523 $ 7,939 $ 24,719 $ 24,738 International 237 362 787 1,347 Total segment depreciation and amortization 8,760 8,301 25,506 26,085 General corporate depreciation and amortization 7,431 3,532 18,062 11,049 Depreciation and amortization $ 16,191 $ 11,833 $ 43,568 $ 37,134

Related Party

Related Party	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related Party	15. Related Party As previously disclosed, on October 18, 2015, the Company entered into the Strategic Collaboration Agreement with Oprah Winfrey, under which she consulted with the Company and participated in developing, planning, executing and enhancing the WW program and related initiatives, and provided it with services in her discretion to promote the Company and its programs, products and services for an initial term of five years (the “Initial Term”). As previously disclosed, on December 15, 2019, the Company entered into an amendment of the Strategic Collaboration Agreement with Ms. Winfrey, pursuant to which, among other things, the Initial Term of the Strategic Collaboration Agreement was extended until April 17, 2023 (with no additional successive renewal terms), after which a second term commenced that will continue through the earlier of the date of the Company’s 2025 annual meeting of shareholders or May 31, 2025. Ms. Winfrey will continue to provide certain consulting and other services to the Company during the second term. In addition to the Strategic Collaboration Agreement, Ms. Winfrey and her related entities provided services to the Company totaling $ 62 and $ 384 for the three and nine months ended September 30, 2023 , respectively, and $ 284 and $ 860 for the three and nine months ended October 1, 2022, respectively, which services included advertising, production and related fees. The Company’s accounts payable to parties related to Ms. Winfrey at September 30, 2023 and December 31, 2022 was $ 61 and $ 0 , respectively.

Restructuring

Restructuring	9 Months Ended
	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring	16. Restructuring 2023 Plan As previously disclosed, in the fourth quarter of fiscal 2022, management reviewed the then-current global business operations of the Company as well as the different functions and systems supporting those operations and contrasted them with the Company's strategic priorities and requirements for fiscal 2023 and beyond. Based on that review, in December 2022, the Company's management resolved to centralize its global management of certain functions and systems, deprioritize and in some cases cease operations for certain non-strategic business lines, and continue the rationalization of its real estate portfolio to align with its future needs. Throughout December 2022 and January 2023, management developed and continued refining a detailed plan to achieve these goals. The Company has committed to a restructuring plan consisting of (i) an organizational restructuring and rationalization of certain functions and systems to centralize the Company’s management, align resources with strategic business lines and reduce costs associated with certain functions and systems (the “Organizational Restructuring”) and (ii) the continued rationalization of its real estate portfolio and resulting operating lease termination charges and the associated employment termination costs (the “Real Estate Restructuring,” and together wit h the Organizational Restructuring, the “2023 Plan”). In connection with the 2023 Plan, the Company previously expected to record restructuring charges of approximately $ 39,000 to $ 46,000 in the aggregate. The Company revised its estimate and currently expects to record restructuring charges in connection with the 2023 Plan of approximately $ 47,000 to $ 54,000 in the aggregate. For the fiscal year ended December 31, 2022, the Company recorded restructuring charges totaling $ 13,608 ($ 10,201 after tax) in connection with the 2023 Plan. For the three and nine months ended September 30, 2023, the Comp any recorded restructuring charges totaling $ 6,187 ($ 4,640 after tax) and $ 30,603 ($ 22,949 after tax), respectively, in connection with the 2023 Plan . The Organizational Restructuring has resulted and will further result in the elimination of certain positions and the termination of employment for certain employees worldwide. In connection with the Organizational Restructuring, the Company previously expected to record restructuring charges of approximately $ 16,000 to $ 19,000 in the aggregate, consisting primarily of general and administrative expenses. The Company revised its estimate and currently expects to record restructuring charges in connection with the Organizational Restructuring of approximately $ 21,000 to $ 26,000 in the aggregate. A significant portion of these charges were recorded in the fourth quarter of fiscal 2022 at the time management resolved to undertake the Organizational Restructuring. For the fiscal year ended December 31, 2022, the Company recorded employee termination benefit costs related to the Organizational Restructuring totaling $ 11,810 ($ 8,853 after tax). For the three and nine months ended September 30, 2023 , the Company recorded employee termination benefit costs related to the Organizational Restructuring totaling $ 4,025 ($ 3,018 after tax) and $ 8,901 ($ 6,675 a fter tax), respectively. In connection with the Real Estate Restructuring, the Company previously expected to record restructuring charges of approximately $ 20,000 to $ 24,000 in the aggregate, the majority of which was recorded in the first quarter of fiscal 2023. The Company revised its estimate and currently expects to record restructuring charges in connection with the Real Estate Restructuring of approximately $ 22,000 to $ 24,000 in the aggregate. For the fiscal year ended December 31, 2022, the Company recorded employee termination benefit costs related to the Real Estate Restructuring totaling $ 1,798 ($ 1,348 after tax). For the three and nine months ended September 30, 2023 , in connection with the Real Estate Restructuring, the Company recorded lease termination and other related costs totaling $( 523 ) ($( 392 ) after tax) and $ 14,371 ($ 10,777 after tax), respectively, and employee termination benefit costs totaling $ 562 ($ 421 after tax) and $ 4,825 ($ 3,618 after tax), respectively. Additionally, the Compa ny previously expected to record other restructuring costs of approximately $ 3,000 in the aggregate in fiscal 2023. The Company revised its estimate and currently expects to record other restructuring charges of approximately $ 4,000 in the aggregate in fiscal 2023. Substantially all of the costs arising from the 2023 Plan are expected to result in cash expenditures related to separation payments, other employee termination expenses and lease termination payments. The Company expects the 2023 Plan to be fully executed by the end of fiscal 2023. For the three and nine months ended September 30, 2023, the components of the Company’s restructuring charges for the 2023 Plan were as follows: Three Months Ended Nine Months Ended September 30, 2023 September 30, 2023 Real Estate Restructuring - Lease termination and other related costs $ ( 523 ) $ 14,371 Real Estate Restructuring - Employee termination benefit costs 562 4,825 Organizational Restructuring - Employee termination benefit costs 4,025 8,901 Other costs 2,123 2,506 Total restructuring charges $ 6,187 $ 30,603 For the three and nine months ended September 30, 2023, restructuring charges for the 2023 Plan were recorded in the Company’s consolidated statements of operations as follows: Three Months Ended Nine Months Ended September 30, 2023 September 30, 2023 Cost of revenues $ 444 $ 19,869 Selling, general and administrative expenses 5,743 10,734 Total restructuring charges $ 6,187 $ 30,603 For the fiscal year ended December 31, 2022, the components of the Company’s restructuring charges for the 2023 Plan were as follows: Fiscal Year Ended December 31, 2022 Real Estate Restructuring - Employee termination benefit costs $ 1,798 Organizational Restructuring - Employee termination benefit costs 11,810 Total restructuring charges $ 13,608 For the fiscal year ended December 31, 2022, restructuring charges for the 2023 Plan were recorded in the Company’s consolidated statements of operations as follows: Fiscal Year Ended December 31, 2022 Cost of revenues $ 1,798 Selling, general and administrative expenses 11,810 Total restructuring charges $ 13,608 All expenses were recorded to general corporate expenses and, therefore, there was no impact to the segments. In connection with the Real Estate Restructuring, for the nine months ended September 30, 2023, the Company made payments of $ 11,224 towards the liability for the lease termination costs and increased provision estimates by $ 67 . In connection with the Real Estate Restructuring, f or the nine months ended September 30, 2023, the Company made payments of $ 4,347 towards the liability for the employee termination benefit costs. In connection with the Organizational Restructuring, for the nine months ended September 30, 2023 , the Company made payments of $ 11,172 towards the liability for the employee termination benefit costs. The Company expects the remaining lease termination liability related to the Real Estate Restructuring of $ 528 , the remaining employee termination benefit liability related to the Real Estate Restructuring of $ 2,275 and the remaining employee termination benefit liability related to the Organizational Restructuring of $ 9,539 to be pai d in full by the end of fiscal 2025. 2022 Plan As previously disclosed, in the second quarter of fiscal 2022, the Company committed to a restructuring plan consisting of (i) an organizational realignment to simplify the Company’s corporate structure and reduce associated costs (the “Organizational Realignment”) and (ii) a continued rationalization of its real estate portfolio resulting in the termination of certain of the Company’s operating leases (together with the Organizational Realignment, the “2022 Plan”). The Organizational Realignment has resulted in the elimination of certain positions and termination of employment for certain employees worldwide. For the fiscal year ended December 31, 2022, the Company recorded restructuring charges totaling $ 27,181 ($ 20,375 after tax). Costs arising from the 2022 Plan related to separation payments, other employee termination expenses and lease termination and other related costs, except for lease impairment and accelerated depreciation and amortization related to leased locations, are expected to result in cash expenditures. For the fiscal year ended December 31, 2022, the components of the Company’s restructuring charges for the 2022 Plan were as follows: Fiscal Year Ended December 31, 2022 Lease termination and other related costs $ 3,791 Employee termination benefit costs 19,170 Lease impairments 2,680 Other costs 1,540 Total restructuring charges $ 27,181 For the fiscal year ended December 31, 2022, restructuring charges for the 2022 Plan were recorded in the Company’s consolidated statements of operations as follows: Fiscal Year Ended December 31, 2022 Cost of revenues $ 6,476 Selling, general and administrative expenses 20,705 Total restructuring charges $ 27,181 All expenses were recorded to general corporate expenses and, therefore, there was no impact to the segments. For the fiscal year ended December 31, 2022, the Company made payments of $ 1,877 towards the liability for the lease termination costs. For the fiscal year ended December 31, 2022, the Company made payments of $ 10,909 towards the liability for the employee termination benefit costs. For the nine months ended September 30, 2023, the Company made pay ments of $ 122 towards the liability for the lease termination costs and decreased provision estimates by $ 425 . For the nine months ended September 30, 2023, the Co mpany made payments of $ 7,636 towards the liability for the employee termination benefit costs and increased provision estimates by $ 1,067 . As of September 30, 2023, there w as no out standing lease termination liability. The Company expects the remaining employee termination benefit liability of $ 1,692 to be paid in full by the end of fiscal 2024. 2021 Plan As previously disclosed, in the first quarter of fiscal 2021, as the Company continued to evaluate its cost structure, anticipate consumer demand and focus on costs, the Company committed to a plan which has resulted in the termination of operating leases and elimination of certain positions worldwide. For the fiscal year ended January 1, 2022, the Company recorded restructuring charges totaling $ 21,534 ($ 16,109 after tax). For the fiscal year ended January 1, 2022, the components of the Company’s restructuring charges were as follows: Fiscal Year Ended January 1, 2022 Lease termination and other related costs $ 12,688 Employee termination benefit costs 8,846 Total restructuring charges $ 21,534 For the fiscal year ended January 1, 2022, restructuring charges were recorded in the Company’s consolidated statements of operations as follows: Fiscal Year Ended January 1, 2022 Cost of revenues $ 16,727 Selling, general and administrative expenses 4,807 Total restructuring charges $ 21,534 All expenses were recorded to general corporate expenses and, therefore, there was no impact to the segments. For the fiscal year ended January 1, 2022, the Company made payments of $ 7,640 towards the liability for the lease termination costs and decreased provision estimates by $ 3 . For the fiscal year ended January 1, 2022, the Company made payments of $ 4,802 towards the liability for the employee termination benefit costs. For the fiscal year ended December 31, 2022, the Company made payments of $ 777 towards the liability for the lease termination costs, decreased provision estimates by $ 681 and incurred additional lease termination and other related costs of $ 119 . For the fiscal year ended December 31, 2022, the Company made payments of $ 3,814 towards the liability for the employee termination benefit costs, increased provision estimates by $ 72 and incurred additional employee termination benefit costs of $ 148 . For the nine months ended September 30, 2023, the Compa ny made payments of $ 507 towards the liability for the employee termination benefit costs and increased provision estimates by $ 57 . As of September 30, 2023, there was no outst anding lease termination liability a nd no outstan ding employee termination benefit liability. 2020 Plan As previously disclosed, in the second quarter of fiscal 2020, in connection with its cost-savings initiative, and its continued response to the COVID-19 pandemic and the related shift in market conditions, the Company committed to a plan of reduction in force which has resulted in the elimination of certain positions and termination of employment for certain employees worldwide. To adjust to anticipated consumer demand, the Company evolved its workshop strategy and expanded its restructuring plan to include lease termination and other related costs. For the fiscal year ended January 2, 2021, the Company recorded restructuring charges totaling $ 33,092 ($ 24,756 after tax). For the fiscal year ended January 2, 2021, the components of the Company’s restructuring charges were as follows: Fiscal Year Ended January 2, 2021 Lease termination and other related costs $ 7,989 Employee termination benefit costs 25,103 Total restructuring charges $ 33,092 For the fiscal year ended January 2, 2021, restructuring charges were recorded in the Company’s consolidated statements of operations as follows: Fiscal Year Ended January 2, 2021 Cost of revenues $ 23,300 Selling, general and administrative expenses 9,792 Total restructuring charges $ 33,092 All expenses were recorded to general corporate expenses and, therefore, there was no impact to the segments. For the fiscal year ended January 2, 2021, the Company made payments of $ 645 towards the liability for the lease termination costs. For the fiscal year ended January 2, 2021, the Company made payments of $ 15,434 towards the liability for the employee termination benefit costs and increased provision estimates by $ 180 . For the fiscal year ended January 1, 2022, the Company made payments of $ 4,649 towards the liability for the lease termination costs and decreased provision estimates by $ 470 . For the fiscal year ended January 1, 2022, the Company made payments of $ 6,773 towards the liability for the employee termination benefit costs and decreased provision estimates by $ 1,136 . For the fiscal year ended December 31, 2022, the Company made payments of $ 86 towards the liability for the lease termination costs and decreased provision estimates by $ 116 . For the fiscal year ended December 31, 2022, the Company made payments of $ 1,202 towards the liability for the employee termination benefit costs and decreased provision estimates by $ 621 . For the nine months ended September 30, 2023, the Company ma de payments of $ 97 towards the liability for the employee termination benefit costs and decreased provision estimates by $ 20 . As of September 30, 2023 , there was no outstanding lease termination liability and no out standing employee termination benefit liability.

Revision of Previously Issued F

Revision of Previously Issued Financial Statements	9 Months Ended
	Sep. 30, 2023
Prior Period Adjustment [Abstract]
Revision of Previously Issued Financial Statements	17. Revision of Previously Issued Financial Statements As disclosed in Note 1, after the three months ended September 30, 2023, the Company identified misstatements in its accounting for income taxes resulting primarily from the recording of a U.S. deferred tax liability related to a foreign branch of the U.S., partially offset by a U.S. deferred tax asset related to its U.S. leases, that should have been recorded in prior fiscal years. The Company concluded that these misstatements were not material, either individually or in aggregate, to its current or previously issued consolidated financial statements, and is revising its previously issued consolidated financial statements to correct for these misstatements. In connection with such revisions, the Company is also correcting for other previously identified immaterial misstatements that were previously corrected as out-of-period adjustments during the year ended December 31, 2022. Due to these misstatements, which originated prior to fiscal 2023, the opening retained earnings balance as of January 1, 2023 was overstated by $ 5,465 due to the net impact of the income tax misstatement of $ 1,965 and other previously identified misstatements of $ 3,500 . Such previously identified misstatements were previously corrected through out-of-period adjustments and included income tax misstatements related to the reversal of (i) a basis difference related to goodwill and other intangibles and (ii) a U.S. federal income tax receivable, in addition to the release of a brand marketing accrual that should have been released in a prior year. The revisions to the accompanying unaudited consolidated statement of operations, consolidated statement of comprehensive loss and consolidated statement of cash flows for the nine months ended October 1, 2022 are presented below. There were no changes to the consolidated statements of operations or comprehensive loss for the three months ended October 1, 2022, or to the consolidated statements of changes in total deficit that have not otherwise been reflected in the consolidated statements of operations and comprehensive loss as detailed in the tables below. Nine Months Ended October 1, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF OPERATIONS Benefit from income taxes $ ( 75,431 ) $ 2,185 $ ( 73,246 ) Net loss $ ( 218,902 ) $ ( 2,185 ) $ ( 221,087 ) Net loss per share Basic $ ( 3.12 ) $ ( 0.03 ) $ ( 3.15 ) Diluted $ ( 3.12 ) $ ( 0.03 ) $ ( 3.15 ) Nine Months Ended October 1, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS Net loss $ ( 218,902 ) $ ( 2,185 ) $ ( 221,087 ) Comprehensive loss $ ( 211,615 ) $ ( 2,185 ) $ ( 213,800 ) Nine Months Ended October 1, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF CASH FLOWS Net loss $ ( 218,902 ) $ ( 2,185 ) $ ( 221,087 ) Changes in cash due to: Income taxes $ ( 392 ) $ 2,185 $ 1,793 Cash provided by operating activities $ 80,546 $ — $ 80,546 The revisions to the unaudited consolidated statement of operations for the three months ended December 31, 2022 are as follows: Three Months Ended December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF OPERATIONS Revenues, net $ 223,924 $ ( 1,021 ) $ 222,903 Gross profit $ 126,990 $ ( 1,021 ) $ 125,969 Operating loss $ ( 50,756 ) $ ( 1,021 ) $ ( 51,777 ) Loss before income taxes $ ( 71,448 ) $ ( 1,021 ) $ ( 72,469 ) Benefit from income taxes $ ( 38,948 ) $ 2,259 $ ( 36,689 ) Net loss $ ( 32,500 ) $ ( 3,280 ) $ ( 35,780 ) Net loss per share Basic $ ( 0.46 ) $ ( 0.05 ) $ ( 0.51 ) Diluted $ ( 0.46 ) $ ( 0.05 ) $ ( 0.51 ) The revisions to the audited consolidated balance sheet, consolidated statement of operations, consolidated statement of comprehensive loss and consolidated statement of cash flows as of and for the year ended December 31, 2022 are presented below. Additionally, the Company will further present the revisions of its previously issued consolidated financial statements and relevant notes to the consolidated financial statements as of and for the year ended December 31, 2022 and prior in connection with the future filing of its 2023 Annual Report on Form 10-K. There were no changes to the consolidated statement of changes in total deficit that have not otherwise been reflected in the consolidated balance sheet and consolidated statements of operations and comprehensive loss as detailed in the tables below. At December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED BALANCE SHEET Deferred income taxes $ 23,119 $ 1,965 $ 25,084 Total Liabilities $ 1,712,245 $ 1,965 $ 1,714,210 Retained earnings $ 2,418,959 $ ( 1,965 ) $ 2,416,994 Total Deficit $ ( 683,815 ) $ ( 1,965 ) $ ( 685,780 ) Fiscal Year Ended December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF OPERATIONS Revenues, net $ 1,040,856 $ ( 1,021 ) $ 1,039,835 Gross profit $ 622,400 $ ( 1,021 ) $ 621,379 Operating loss $ ( 282,950 ) $ ( 1,021 ) $ ( 283,971 ) Loss before income taxes $ ( 365,782 ) $ ( 1,021 ) $ ( 366,803 ) Benefit from income taxes $ ( 114,379 ) $ 4,444 $ ( 109,935 ) Net loss $ ( 251,403 ) $ ( 5,465 ) $ ( 256,868 ) Net loss per share Basic $ ( 3.58 ) $ ( 0.08 ) $ ( 3.65 ) Diluted $ ( 3.58 ) $ ( 0.08 ) $ ( 3.65 ) Fiscal Year Ended December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS Net loss $ ( 251,403 ) $ ( 5,465 ) $ ( 256,868 ) Comprehensive loss $ ( 238,269 ) $ ( 5,465 ) $ ( 243,734 ) Fiscal Year Ended December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF CASH FLOWS Net loss $ ( 251,403 ) $ ( 5,465 ) $ ( 256,868 ) Changes in cash due to: Prepaid expenses $ 9,599 $ ( 721 ) $ 8,878 Accrued liabilities $ 19,904 $ 1,021 $ 20,925 Income taxes $ ( 588 ) $ 5,165 $ 4,577 Cash provided by operating activities $ 76,646 $ — $ 76,646

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Use of Estimates	The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and include amounts that are based on management’s best estimates and judgments. While all available information has been considered, actual amounts could differ from those estimates. These assumptions and estimates may change as new events occur and additional information is obtained, and such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity.
Variable Interest Entity	The Company evaluates its ownership, contractual and other interests in entities to determine if it has any variable interest in a variable interest entity (“VIE” ). These evaluations are complex and involve judgment and the use of estimates and assumptions based on available information. If the Company determines that an entity in which it holds a contractual or ownership interest is a VIE and that the Company is the primary beneficiary, such entity is consolidated in the Company’s consolidated financial statements. The primary beneficiary of a VIE is the party that meets both of the following criteria: (i) has the power to make decisions that most significantly affect the economic performance of the VIE; and (ii) has the obligation to absorb losses or the right to receive benefits that in either case could potentially be significant to the VIE. The Company performs ongoing reassessments of whether changes in the facts and circumstances regarding the Company’s involvement with a VIE will cause the consolidation conclusion to change. The Company operates certain clinical telehealth groups which are deemed to be Friendly-Physician Entities (“FPEs”) and due to legal requirements, the physician-owners must retain 100 % of the equity interest. The Company’s agreements with FPEs generally consist of both an Administrative Service Agreement, which provides for various administrative and management services to be provided by the Company to the FPE, and Stock Transfer Restriction (“STR”) agreements with the physician-owners of the FPEs, which provide for the transition of ownership interest of the FPEs under certain conditions. The Company has the right to receive income as an ongoing management fee, which effectively absorbs all of the residual interests, and can also provide financial support through loans to the FPEs. The Company has exclusive responsibility for the provision of all nonmedical services including technology and intellectual property required for the day-to-day operation and management of each of the FPEs. In addition, the STR agreements provide that the Company has the right to designate a person(s) to purchase the equity interest of the FPE for a nominal amount in the event of a succession event at the Company’s discretion. Based on the provisions of these agreements, the Company determined that the FPEs are VIEs due to their equity holder having insufficient capital at risk, and the Company has a variable interest in the FPEs. The contractual arrangements described above allow Sequence to direct the activities that most significantly affect the economic performance of the FPEs. Accordingly, Sequence is the primary ben eficiary of the FPEs and consolidates the FPEs under the VIE model. Furthermore, as a direct result of nominal initial equity contributions by the physicians, the financial support the Company can provide to the FPEs (e.g., loans) and the provisions of the contractual arrangements and nominee shareholder succession arrangements described above, the interests held by noncontrolling interest holders lack economic substance and do not provide them with the ability to participate in the residual profits or losses generated by the FPEs. Therefore, all income and expenses recognized by the FPEs are consolidated by the Company. The Company does not hold interests in any VIEs for which the Company is not deemed to be the primary beneficiary.
Revision of Previously Issued Consolidated Financial Statements	Revision of Previously Issued Consolidated Financial Statements After the three months ended September 30, 2023, the Company identified misstatements in its accounting for income taxes resulting primarily from the recording of a U.S. deferred tax liability related to a foreign branch of the U.S., partially offset by a U.S. deferred tax asset related to its U.S. leases, that should have been recorded in prior fiscal years. The Company evaluated the misstatements and concluded that the misstatements were not material, either individually or in aggregate, to its current or previously issued consolidated financial statements. To correct the immaterial misstatements, the Company has revised its previously issued consolidated financial statements as of and for the year ended December 31, 2022 and its unaudited consolidated financial statements for the nine months ended October 1, 2022. The revision of the historical consolidated financial statements also includes the correction of other immaterial misstatements that the Company had previously recorded as out-of-period adjustments. The Company had previously determined that these previously identified misstatements did not, either individually or in the aggregate, result in a material misstatement of its previously issued consolidated financial statements and reached the same conclusion when aggregating the previously identified misstatements with the recently identified misstatements. See Note 17 for further information regarding the misstatements and related revisions. The accompanying financial statements and relevant notes to the consolidated financial statements for the periods referenced above in this Quarterly Report on Form 10-Q have been revised to correct for such misstatements. Additionally, the Company will further present the revisions of its previously issued consolidated financial statements and relevant notes to the consolidated financial statements as of and for the year ended December 31, 2022 and prior in connection with the future filing of its 2023 Annual Report on Form 10-K.
Revenue Recognition	Revenues are recognized when control of the promised services or goods is transferred to the Company’s customers, in an amount that reflects the consideration it expects to be entitled to in exchange for those services or goods.

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Schedule of Lease Assets and Lease Liabilities	At September 30, 2023 and December 31, 2022, the Company’s lease assets and lease liabilities, primarily for its studios and corporate offices, were as follows: September 30, 2023 December 31, 2022 Assets: Operating leases $ 55,414 $ 75,696 Finance leases 10 54 Total lease assets $ 55,424 $ 75,750 Liabilities: Current Operating leases $ 9,804 $ 17,955 Finance leases 9 31 Noncurrent Operating leases 56,643 68,099 Finance leases 0 7 Total lease liabilities $ 66,456 $ 86,092
Schedule of Components of Lease Expense	For the three and nine months ended September 30, 2023 and October 1, 2022, the components of the Company’s lease expense were as follows: Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Operating lease cost: Fixed lease cost $ 4,312 $ 9,071 $ 17,423 $ 24,974 Lease termination (benefit) cost ( 538 ) ( 189 ) 11,512 1,912 Variable lease cost 15 7 46 20 Total operating lease cost $ 3,789 $ 8,889 $ 28,981 $ 26,906 Finance lease cost: Amortization of leased assets 5 25 $ 43 $ 86 Interest on lease liabilities 0 4 1 6 Total finance lease cost $ 5 $ 29 $ 44 $ 92 Total lease cost $ 3,794 $ 8,918 $ 29,025 $ 26,998
Summary of Weighted Average Remaining Lease Term and Weighted Average Discount Rates	At September 30, 2023 and December 31, 2022, the Company’s weighted average remaining lease term and weighted average discount rates were as follows: September 30, 2023 December 31, 2022 Weighted Average Remaining Lease Term (years) Operating leases 7.42 6.90 Finance leases 0.62 1.00 Weighted Average Discount Rate Operating leases 7.48 7.03 Finance leases 3.91 3.52
Schedule of Maturity of Lease Liabilities	At September 30, 2023, the maturity of the Company’s lease liabilities in each of the next five fiscal years and thereafter were as follows: Operating Finance Total Remainder of fiscal 2023 $ 2,778 $ 2 $ 2,780 Fiscal 2024 15,307 7 15,314 Fiscal 2025 13,054 — 13,054 Fiscal 2026 10,056 — 10,056 Fiscal 2027 9,590 — 9,590 Fiscal 2028 9,277 — 9,277 Thereafter 26,919 — 26,919 Total lease payments $ 86,981 $ 9 $ 86,990 Less imputed interest 20,534 0 20,534 Present value of lease liabilities $ 66,447 $ 9 $ 66,456
Summary of Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases for the nine months ended September 30, 2023 and October 1, 2022 were as follows: Nine Months Ended September 30, October 1, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 17,826 $ 24,244 Operating cash flows from finance leases $ 1 $ 6 Financing cash flows from finance leases $ 43 $ 86 Lease assets (modified) obtained in exchange for (modified) new operating lease liabilities $ ( 6,683 ) $ 11,160 Lease assets obtained in exchange for new finance lease liabilities $ — $ 44

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Revenues Disaggregated by Revenue Source	The following table presents the Company’s revenues disaggregated by revenue source: Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Digital Subscription Revenues $ 140,889 $ 155,881 $ 437,613 $ 521,582 Workshops + Digital Fees 52,618 64,865 171,473 196,540 Clinical Subscription Revenues 9,989 — 17,581 — Subscription Revenues, net $ 203,496 $ 220,746 $ 626,667 $ 718,122 Product sales and other, net 11,375 28,972 56,927 98,810 Revenues, net $ 214,871 $ 249,718 $ 683,594 $ 816,932
Schedule of Revenues Disaggregated by Revenue Source and Segment	The following tables present the Company’s revenues disaggregated by revenue source and segment: Three Months Ended September 30, 2023 North America International Total Digital Subscription Revenues $ 92,437 $ 48,452 $ 140,889 Workshops + Digital Fees 42,867 9,751 52,618 Clinical Subscription Revenues 9,989 — 9,989 Subscription Revenues, net $ 145,293 $ 58,203 $ 203,496 Product sales and other, net 9,394 1,981 11,375 Revenues, net $ 154,687 $ 60,184 $ 214,871 Three Months Ended October 1, 2022 North America International Total Digital Subscription Revenues $ 102,735 $ 53,146 $ 155,881 Workshops + Digital Fees 52,113 12,752 64,865 Subscription Revenues, net $ 154,848 $ 65,898 $ 220,746 Product sales and other, net 21,621 7,351 28,972 Revenues, net $ 176,469 $ 73,249 $ 249,718 Nine Months Ended September 30, 2023 North America International Total Digital Subscription Revenues $ 285,655 $ 151,958 $ 437,613 Workshops + Digital Fees 138,639 32,834 171,473 Clinical Subscription Revenues 17,581 — 17,581 Subscription Revenues, net $ 441,875 $ 184,792 $ 626,667 Product sales and other, net 46,025 10,902 56,927 Revenues, net $ 487,900 $ 195,694 $ 683,594 Nine Months Ended October 1, 2022 North America International Total Digital Subscription Revenues $ 342,489 $ 179,093 $ 521,582 Workshops + Digital Fees 155,558 40,982 196,540 Subscription Revenues, net $ 498,047 $ 220,075 $ 718,122 Product sales and other, net 71,478 27,332 98,810 Revenues, net $ 569,525 $ 247,407 $ 816,932
Schedule of Deferred Revenues	The opening and ending balances of the Company’s deferred revenues were as follows: Deferred Deferred Revenue Revenue-Long Term Balance as of December 31, 2022 $ 32,156 $ 360 Net increase (decrease) during the period 289 ( 155 ) Balance as of September 30, 2023 $ 32,445 $ 205 Balance as of January 1, 2022 $ 45,855 $ 28 Net (decrease) increase during the period ( 6,083 ) 11 Balance as of October 1, 2022 $ 39,772 $ 39

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2023
Business Combinations [Abstract]
Summary of Purchase Price Allocation for Acquired Identifiable Assets, Liabilities Assumed and Goodwill	The following table shows the purchase price allocation for Sequence to the acquired identifiable assets, liabilities assumed and goodwill: Total consideration: Cash paid at closing $ 64,217 Cash to be paid on April 10, 2024 16,000 Cash to be paid on April 10, 2025 (1) 12,420 Total cash payments $ 92,637 Less stock-based compensation expense attributable to post combination vesting ( 3,882 ) Common shares issued 7,996 Stock price as of April 10, 2023 (2) $ 4.12 Total stock issuance purchase price (2) 32,943 Aggregated merger consideration $ 121,698 Assets acquired: Cash $ 25,776 Prepaid expenses and other current assets 2,220 Property, plant and equipment 34 Intangible assets 7,768 Total assets acquired 35,798 Liabilities assumed: Accounts payable $ 70 Accrued liabilities 14 Deferred revenue 1,300 Deferred tax liability 1,906 Total liabilities assumed 3,290 Net assets acquired 32,508 Total goodwill $ 89,190 (1) Reflects $ 16,000 of cash payable on April 10, 2025 as Merger Consideration discounted using the Company's weighted average cost of debt. (2) Represents the fair value of the shares transferred to the sellers, based on the number of shares to be issued, 7,996 , multiplied by the closing price of the Company's ordinary shares on April 10, 2023 of $ 4.12 per share.

Franchise Rights Acquired, Go_2

Franchise Rights Acquired, Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Change in Carrying Amount of Goodwill	For the nine months ended September 30, 2023, the change in the carrying amount of goodwill was due to the acquisition of Sequence and the effect of exchange rate changes as follows: North America International Total Balance as of January 1, 2022 $ 147,530 $ 9,844 $ 157,374 Goodwill acquired during the period — 5,936 5,936 Goodwill impairment ( 1,101 ) ( 2,023 ) ( 3,124 ) Effect of exchange rate changes ( 2,862 ) ( 1,326 ) ( 4,188 ) Balance as of December 31, 2022 $ 143,567 $ 12,431 $ 155,998 Goodwill acquired during the period 89,190 — 89,190 Effect of exchange rate changes ( 6 ) ( 255 ) ( 261 ) Balance as of September 30, 2023 $ 232,751 $ 12,176 $ 244,927
Schedule of Assumptions Utilized in Annual Goodwill Impairment Analysis	The following are the more significant assumptions utilized in the Company's annual goodwill impairment analyses for fiscal 2023 and fiscal 2022: Fiscal 2023 Fiscal 2022 Debt-Free Cumulative Annual Cash Flow Growth Rate 3.9 % to 24.9 % 1.2 % to 20.6 % Discount Rate 10.8 % 9.6 %
Schedule of Carrying Values of Finite-lived Intangible Assets	The carrying values of finite-lived intangible assets as of September 30, 2023 and December 31, 2022 were as follows: September 30, 2023 December 31, 2022 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Capitalized software costs $ 109,250 $ 101,753 $ 107,229 $ 94,375 Website development costs 164,975 113,570 133,818 91,482 Trademarks 12,177 12,003 12,162 11,882 Other 13,949 6,493 13,961 6,125 Trademarks and other intangible assets $ 300,351 $ 233,819 $ 267,170 $ 203,864 Franchise rights acquired 8,209 5,373 8,164 5,101 Total finite-lived intangible assets $ 308,560 $ 239,192 $ 275,334 $ 208,965
Schedule of Estimated Amortization Expense of Finite-lived Intangible Assets	Estimated amortization expense of existing finite-lived intangible assets for the next five fiscal years and thereafter is as follows: Remainder of fiscal 2023 $ 10,937 Fiscal 2024 $ 27,292 Fiscal 2025 $ 17,679 Fiscal 2026 $ 5,500 Fiscal 2027 $ 725 Fiscal 2028 $ 533 Thereafter $ 6,702

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Components of Long-Term Debt	The components of the Company’s long-term debt were as follows: September 30, 2023 December 31, 2022 Principal Unamortized Unamortized Effective (1) Principal Unamortized Unamortized Effective (1) Revolving Credit Facility due $ — $ — $ — 0.00 % $ — $ — $ — 0.00 % Term Loan Facility due 945,000 4,989 10,340 8.99 % 945,000 5,821 12,064 5.85 % Senior Secured Notes due 500,000 4,252 — 4.65 % 500,000 4,831 — 4.70 % Total $ 1,445,000 $ 9,241 $ 10,340 7.48 % $ 1,445,000 $ 10,652 $ 12,064 5.45 % Less: Current portion — — Unamortized deferred 9,241 10,652 Unamortized debt discount 10,340 12,064 Total long-term debt $ 1,425,419 $ 1,422,284 (1) Includes amortization of deferred financing costs and debt discount.

Per Share Data (Tables)

Per Share Data (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted earnings (net loss) per share: Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Numerator: Net income (loss) $ 43,731 $ ( 206,036 ) $ ( 24,120 ) $ ( 221,087 ) Denominator: Weighted average shares of common stock outstanding 78,979 70,383 75,861 70,258 Effect of dilutive common stock equivalents 1,659 — — — Weighted average diluted common shares outstanding 80,638 70,383 75,861 70,258 Earnings (net loss) per share Basic $ 0.55 $ ( 2.93 ) $ ( 0.32 ) $ ( 3.15 ) Diluted $ 0.54 $ ( 2.93 ) $ ( 0.32 ) $ ( 3.15 )

Derivative Instruments and He_2

Derivative Instruments and Hedging (Tables)	9 Months Ended
	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Aggregate Fair Value of Derivative Financial Instruments by Balance Sheet Classification and Location	The following table presents the aggregate fair value of the Company’s derivative financial instruments by balance sheet classification and location: Fair Value Balance Sheet Classification Balance Sheet September 30, 2023 December 31, 2022 Assets: Interest rate swaps - current swaps Current asset Prepaid expenses and other current assets $ 7,272 $ 11,748 Interest rate swaps - current swaps Noncurrent asset Other noncurrent assets — 2,450 Total assets $ 7,272 $ 14,198

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Aggregate Fair Value of Derivative Financial Instruments	The following table presents the aggregate fair value of the Company’s derivative financial instruments: Fair Value Measurements Using: Total Quoted Prices in Significant Other Significant Interest rate swap current asset at September 30, 2023 $ 7,272 $ — $ 7,272 $ — Interest rate swap current asset at December 31, 2022 $ 11,748 $ — $ 11,748 $ — Interest rate swap noncurrent asset at December 31, 2022 $ 2,450 $ — $ 2,450 $ —

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Changes in Accumulated Other Comprehensive Loss by Component	Amounts reclassified out of accumulated other comprehensive loss were as follows: Changes in Accumulated Other Comprehensive Loss by Component (1) Nine Months Ended September 30, 2023 Gain on Loss on Total Beginning balance at December 31, 2022 $ 10,723 $ ( 16,193 ) $ ( 5,470 ) Other comprehensive income (loss) before reclassifications, net of tax 1,778 ( 1,282 ) 496 Amounts reclassified from accumulated other comprehensive loss, net of tax (2) ( 6,994 ) — ( 6,994 ) Net current period other comprehensive loss $ ( 5,216 ) $ ( 1,282 ) $ ( 6,498 ) Ending balance at September 30, 2023 $ 5,507 $ ( 17,475 ) $ ( 11,968 ) (1) Amounts in parentheses indicate debits (2) See separate table below for details about these reclassifications Nine Months Ended October 1, 2022 (Loss) Gain on Loss on Total Beginning balance at January 1, 2022 $ ( 10,843 ) $ ( 7,761 ) $ ( 18,604 ) Other comprehensive income (loss) before reclassifications, net of tax 17,350 ( 13,488 ) 3,862 Amounts reclassified from accumulated other comprehensive loss, net of tax (2) 3,425 — 3,425 Net current period other comprehensive income (loss) $ 20,775 $ ( 13,488 ) $ 7,287 Ending balance at October 1, 2022 $ 9,932 $ ( 21,249 ) $ ( 11,317 ) (1) Amounts in parentheses indicate debits (2) See separate table below for details about these reclassifications
Reclassifications out of Accumulated Other Comprehensive Loss	Reclassifications out of Accumulated Other Comprehensive Loss (1) Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Details about Other Comprehensive Amounts Reclassified from Amounts Reclassified from Affected Line Item in the Gain (Loss) on Qualifying Hedges Interest rate contracts $ 3,559 $ ( 326 ) $ 9,327 $ ( 4,575 ) Interest expense 3,559 ( 326 ) 9,327 ( 4,575 ) Income (loss) before income taxes ( 890 ) 82 ( 2,333 ) 1,150 Benefit from income taxes $ 2,669 $ ( 244 ) $ 6,994 $ ( 3,425 ) Net income (loss) (1) Amounts in parentheses indicate debits to profit/loss

Segment Data (Tables)

Segment Data (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Information About Reportable Segments	Information about the Company’s reportable segments is as follows: Total Revenues, net Total Revenues, net Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 North America $ 154,687 $ 176,469 $ 487,900 $ 569,525 International 60,184 73,249 195,694 247,407 Total revenues, net $ 214,871 $ 249,718 $ 683,594 $ 816,932 Net Income (Loss) Net Loss Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Segment operating income (loss): North America $ 36,064 $ ( 255,102 ) $ 81,850 $ ( 207,039 ) International 23,675 29,074 55,797 77,216 Total segment operating income (loss) 59,739 ( 226,028 ) 137,647 ( 129,823 ) General corporate expenses 29,132 28,501 109,307 102,370 Interest expense 24,508 20,912 71,429 58,837 Other expense (income), net 815 1,344 ( 36 ) 3,303 Benefit from income taxes ( 38,447 ) ( 70,749 ) ( 18,933 ) ( 73,246 ) Net income (loss) $ 43,731 $ ( 206,036 ) $ ( 24,120 ) $ ( 221,087 ) Depreciation and Amortization Depreciation and Amortization Three Months Ended Nine Months Ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 North America $ 8,523 $ 7,939 $ 24,719 $ 24,738 International 237 362 787 1,347 Total segment depreciation and amortization 8,760 8,301 25,506 26,085 General corporate depreciation and amortization 7,431 3,532 18,062 11,049 Depreciation and amortization $ 16,191 $ 11,833 $ 43,568 $ 37,134

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Charges	For the three and nine months ended September 30, 2023, the components of the Company’s restructuring charges for the 2023 Plan were as follows: Three Months Ended Nine Months Ended September 30, 2023 September 30, 2023 Real Estate Restructuring - Lease termination and other related costs $ ( 523 ) $ 14,371 Real Estate Restructuring - Employee termination benefit costs 562 4,825 Organizational Restructuring - Employee termination benefit costs 4,025 8,901 Other costs 2,123 2,506 Total restructuring charges $ 6,187 $ 30,603 For the three and nine months ended September 30, 2023, restructuring charges for the 2023 Plan were recorded in the Company’s consolidated statements of operations as follows: Three Months Ended Nine Months Ended September 30, 2023 September 30, 2023 Cost of revenues $ 444 $ 19,869 Selling, general and administrative expenses 5,743 10,734 Total restructuring charges $ 6,187 $ 30,603 For the fiscal year ended December 31, 2022, the components of the Company’s restructuring charges for the 2023 Plan were as follows: Fiscal Year Ended December 31, 2022 Real Estate Restructuring - Employee termination benefit costs $ 1,798 Organizational Restructuring - Employee termination benefit costs 11,810 Total restructuring charges $ 13,608 For the fiscal year ended December 31, 2022, restructuring charges for the 2023 Plan were recorded in the Company’s consolidated statements of operations as follows: Fiscal Year Ended December 31, 2022 Cost of revenues $ 1,798 Selling, general and administrative expenses 11,810 Total restructuring charges $ 13,608 For the fiscal year ended December 31, 2022, the components of the Company’s restructuring charges for the 2022 Plan were as follows: Fiscal Year Ended December 31, 2022 Lease termination and other related costs $ 3,791 Employee termination benefit costs 19,170 Lease impairments 2,680 Other costs 1,540 Total restructuring charges $ 27,181 For the fiscal year ended December 31, 2022, restructuring charges for the 2022 Plan were recorded in the Company’s consolidated statements of operations as follows: Fiscal Year Ended December 31, 2022 Cost of revenues $ 6,476 Selling, general and administrative expenses 20,705 Total restructuring charges $ 27,181 For the fiscal year ended January 1, 2022, the components of the Company’s restructuring charges were as follows: Fiscal Year Ended January 1, 2022 Lease termination and other related costs $ 12,688 Employee termination benefit costs 8,846 Total restructuring charges $ 21,534 For the fiscal year ended January 1, 2022, restructuring charges were recorded in the Company’s consolidated statements of operations as follows: Fiscal Year Ended January 1, 2022 Cost of revenues $ 16,727 Selling, general and administrative expenses 4,807 Total restructuring charges $ 21,534 For the fiscal year ended January 2, 2021, the components of the Company’s restructuring charges were as follows: Fiscal Year Ended January 2, 2021 Lease termination and other related costs $ 7,989 Employee termination benefit costs 25,103 Total restructuring charges $ 33,092 For the fiscal year ended January 2, 2021, restructuring charges were recorded in the Company’s consolidated statements of operations as follows: Fiscal Year Ended January 2, 2021 Cost of revenues $ 23,300 Selling, general and administrative expenses 9,792 Total restructuring charges $ 33,092

Revision of Previously Issued_2

Revision of Previously Issued Financial Statements (Tables)	9 Months Ended
	Sep. 30, 2023
Prior Period Adjustment [Abstract]
Schedule of Error Corrections and Prior Period Adjustments	Nine Months Ended October 1, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF OPERATIONS Benefit from income taxes $ ( 75,431 ) $ 2,185 $ ( 73,246 ) Net loss $ ( 218,902 ) $ ( 2,185 ) $ ( 221,087 ) Net loss per share Basic $ ( 3.12 ) $ ( 0.03 ) $ ( 3.15 ) Diluted $ ( 3.12 ) $ ( 0.03 ) $ ( 3.15 ) Nine Months Ended October 1, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS Net loss $ ( 218,902 ) $ ( 2,185 ) $ ( 221,087 ) Comprehensive loss $ ( 211,615 ) $ ( 2,185 ) $ ( 213,800 ) Nine Months Ended October 1, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF CASH FLOWS Net loss $ ( 218,902 ) $ ( 2,185 ) $ ( 221,087 ) Changes in cash due to: Income taxes $ ( 392 ) $ 2,185 $ 1,793 Cash provided by operating activities $ 80,546 $ — $ 80,546 The revisions to the unaudited consolidated statement of operations for the three months ended December 31, 2022 are as follows: Three Months Ended December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF OPERATIONS Revenues, net $ 223,924 $ ( 1,021 ) $ 222,903 Gross profit $ 126,990 $ ( 1,021 ) $ 125,969 Operating loss $ ( 50,756 ) $ ( 1,021 ) $ ( 51,777 ) Loss before income taxes $ ( 71,448 ) $ ( 1,021 ) $ ( 72,469 ) Benefit from income taxes $ ( 38,948 ) $ 2,259 $ ( 36,689 ) Net loss $ ( 32,500 ) $ ( 3,280 ) $ ( 35,780 ) Net loss per share Basic $ ( 0.46 ) $ ( 0.05 ) $ ( 0.51 ) Diluted $ ( 0.46 ) $ ( 0.05 ) $ ( 0.51 ) The revisions to the audited consolidated balance sheet, consolidated statement of operations, consolidated statement of comprehensive loss and consolidated statement of cash flows as of and for the year ended December 31, 2022 are presented below. Additionally, the Company will further present the revisions of its previously issued consolidated financial statements and relevant notes to the consolidated financial statements as of and for the year ended December 31, 2022 and prior in connection with the future filing of its 2023 Annual Report on Form 10-K. There were no changes to the consolidated statement of changes in total deficit that have not otherwise been reflected in the consolidated balance sheet and consolidated statements of operations and comprehensive loss as detailed in the tables below. At December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED BALANCE SHEET Deferred income taxes $ 23,119 $ 1,965 $ 25,084 Total Liabilities $ 1,712,245 $ 1,965 $ 1,714,210 Retained earnings $ 2,418,959 $ ( 1,965 ) $ 2,416,994 Total Deficit $ ( 683,815 ) $ ( 1,965 ) $ ( 685,780 ) Fiscal Year Ended December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF OPERATIONS Revenues, net $ 1,040,856 $ ( 1,021 ) $ 1,039,835 Gross profit $ 622,400 $ ( 1,021 ) $ 621,379 Operating loss $ ( 282,950 ) $ ( 1,021 ) $ ( 283,971 ) Loss before income taxes $ ( 365,782 ) $ ( 1,021 ) $ ( 366,803 ) Benefit from income taxes $ ( 114,379 ) $ 4,444 $ ( 109,935 ) Net loss $ ( 251,403 ) $ ( 5,465 ) $ ( 256,868 ) Net loss per share Basic $ ( 3.58 ) $ ( 0.08 ) $ ( 3.65 ) Diluted $ ( 3.58 ) $ ( 0.08 ) $ ( 3.65 ) Fiscal Year Ended December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS Net loss $ ( 251,403 ) $ ( 5,465 ) $ ( 256,868 ) Comprehensive loss $ ( 238,269 ) $ ( 5,465 ) $ ( 243,734 ) Fiscal Year Ended December 31, 2022 As Previously Reported Adjustments As Revised CONSOLIDATED STATEMENT OF CASH FLOWS Net loss $ ( 251,403 ) $ ( 5,465 ) $ ( 256,868 ) Changes in cash due to: Prepaid expenses $ 9,599 $ ( 721 ) $ 8,878 Accrued liabilities $ 19,904 $ 1,021 $ 20,925 Income taxes $ ( 588 ) $ 5,165 $ 4,577 Cash provided by operating activities $ 76,646 $ — $ 76,646

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2023
Income Taxes [Line Items]
Percentage of equity interest of physician-owners	100%

Leases - Schedule of Lease Asse

Leases - Schedule of Lease Assets and Lease Liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Assets:
Operating leases assets	$ 55,414	$ 75,696
Finance leases assets	$ 10	$ 54
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property and equipment, net	Property and equipment, net
Total lease assets	$ 55,424	$ 75,750
Current
Operating leases	9,804	17,955
Finance leases	$ 9	$ 31
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other accrued liabilities	Other accrued liabilities
Noncurrent
Operating leases	$ 56,643	$ 68,099
Finance leases	$ 0	$ 7
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other	Other
Total lease liabilities	$ 66,456	$ 86,092

Leases - Schedule of Components

Leases - Schedule of Components of Lease Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Operating lease cost:
Fixed lease cost	$ 4,312	$ 9,071	$ 17,423	$ 24,974
Lease termination (benefit) cost	(538)	(189)	11,512	1,912
Variable lease cost	15	7	46	20
Total operating lease cost	3,789	8,889	28,981	26,906
Finance lease cost:
Amortization of leased assets	5	25	43	86
Interest on lease liabilities	0	4	1	6
Total finance lease cost	5	29	44	92
Total lease cost	$ 3,794	$ 8,918	$ 29,025	$ 26,998

Leases - Additional Information

Leases - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Lessee Lease Description [Line Items]
Sublease income	$ 931	$ 2,455
Lease weighted average remaining lease term		7 years 5 months 1 day
Minimum
Lessee Lease Description [Line Items]
Leases, remaining lease term		0 years
Maximum
Lessee Lease Description [Line Items]
Leases, remaining lease term		9 years

Leases - Summary of Weighted Av

Leases - Summary of Weighted Average Remaining Lease Term and Weighted Average Discount Rates (Detail)	Sep. 30, 2023	Dec. 31, 2022
Weighted Average Remaining Lease Term (years)
Operating leases	7 years 5 months 1 day	6 years 10 months 24 days
Finance leases	7 months 13 days	1 year
Weighted Average Discount Rate
Operating leases	7.48%	7.03%
Finance leases	3.91%	3.52%

Leases - Schedule of Maturity o

Leases - Schedule of Maturity of Lease Liabilities (Detail) $ in Thousands	Sep. 30, 2023 USD ($)
Operating Leases
Remainder of fiscal 2023	$ 2,778
Fiscal 2024	15,307
Fiscal 2025	13,054
Fiscal 2026	10,056
Fiscal 2027	9,590
Fiscal 2028	9,277
Thereafter	26,919
Total lease payments	86,981
Less imputed interest	20,534
Present value of lease liabilities	66,447
Finance Leases
Remainder of fiscal 2023	2
Fiscal 2024	7
Total lease payments	9
Less imputed interest	0
Present value of lease liabilities	9
Total
Remainder of fiscal 2023	2,780
Fiscal 2024	15,314
Fiscal 2025	13,054
Fiscal 2026	10,056
Fiscal 2027	9,590
Fiscal 2028	9,277
Thereafter	26,919
Total lease payments	86,990
Less imputed interest	20,534
Present value of lease liabilities	$ 66,456

Leases - Summary of Supplementa

Leases - Summary of Supplemental Cash Flow Information Related to Leases (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$ 17,826	$ 24,244
Operating cash flows from finance leases	1	6
Financing cash flows from finance leases	43	86
Lease assets (modified) obtained in exchange for (modified) new operating lease liabilities	$ (6,683)	11,160
Lease assets obtained in exchange for new finance lease liabilities		$ 44

Revenue - Schedule of Revenues

Revenue - Schedule of Revenues Disaggregated by Revenue Source (Detail) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Disaggregation Of Revenue [Line Items]
Revenues, net	$ 214,871	$ 222,903	$ 249,718	$ 683,594	$ 816,932	$ 1,039,835
Digital Subscription Revenues
Disaggregation Of Revenue [Line Items]
Revenues, net	140,889		155,881	437,613	521,582
Workshops + Digital Fees
Disaggregation Of Revenue [Line Items]
Revenues, net	52,618		64,865	171,473	196,540
Clinical Subscription Revenues
Disaggregation Of Revenue [Line Items]
Revenues, net	9,989			17,581
Subscription Revenues, net
Disaggregation Of Revenue [Line Items]
Revenues, net	203,496		220,746	626,667	718,122
Product sales and other, net
Disaggregation Of Revenue [Line Items]
Revenues, net	$ 11,375		$ 28,972	$ 56,927	$ 98,810

Revenue - Schedule of Revenue_2

Revenue - Schedule of Revenues Disaggregated by Revenue Source and Segment (Detail) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Disaggregation Of Revenue [Line Items]
Revenues, net	$ 214,871	$ 222,903	$ 249,718	$ 683,594	$ 816,932	$ 1,039,835
North America
Disaggregation Of Revenue [Line Items]
Revenues, net	154,687		176,469	487,900	569,525
International
Disaggregation Of Revenue [Line Items]
Revenues, net	60,184		73,249	195,694	247,407
Digital Subscription Revenues
Disaggregation Of Revenue [Line Items]
Revenues, net	140,889		155,881	437,613	521,582
Digital Subscription Revenues | North America
Disaggregation Of Revenue [Line Items]
Revenues, net	92,437		102,735	285,655	342,489
Digital Subscription Revenues | International
Disaggregation Of Revenue [Line Items]
Revenues, net	48,452		53,146	151,958	179,093
Workshops + Digital Fees
Disaggregation Of Revenue [Line Items]
Revenues, net	52,618		64,865	171,473	196,540
Workshops + Digital Fees | North America
Disaggregation Of Revenue [Line Items]
Revenues, net	42,867		52,113	138,639	155,558
Workshops + Digital Fees | International
Disaggregation Of Revenue [Line Items]
Revenues, net	9,751		12,752	32,834	40,982
Clinical Subscription Revenues
Disaggregation Of Revenue [Line Items]
Revenues, net	9,989			17,581
Clinical Subscription Revenues | North America
Disaggregation Of Revenue [Line Items]
Revenues, net	9,989			17,581
Subscription Revenues, net
Disaggregation Of Revenue [Line Items]
Revenues, net	203,496		220,746	626,667	718,122
Subscription Revenues, net | North America
Disaggregation Of Revenue [Line Items]
Revenues, net	145,293		154,848	441,875	498,047
Subscription Revenues, net | International
Disaggregation Of Revenue [Line Items]
Revenues, net	58,203		65,898	184,792	220,075
Product sales and other, net
Disaggregation Of Revenue [Line Items]
Revenues, net	11,375		28,972	56,927	98,810
Product sales and other, net | North America
Disaggregation Of Revenue [Line Items]
Revenues, net	9,394		21,621	46,025	71,478
Product sales and other, net | International
Disaggregation Of Revenue [Line Items]
Revenues, net	$ 1,981		$ 7,351	$ 10,902	$ 27,332

Revenue - Schedule of Deferred

Revenue - Schedule of Deferred Revenues (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022
Deferred Revenue - Short Term
Contract With Customer Asset And Liability [Line Items]
Deferred Revenue, Beginning balance	$ 32,156	$ 45,855
Net increase (decrease) during the period	289	(6,083)
Deferred Revenue, Ending balance	32,445	39,772
Deferred Revenue - Long Term
Contract With Customer Asset And Liability [Line Items]
Deferred Revenue, Beginning balance	360	28
Net increase (decrease) during the period	(155)	11
Deferred Revenue, Ending balance	$ 205	$ 39

Revenue - Additional Informatio

Revenue - Additional Information (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022
Revenues [Abstract]
Deferred revenue recognized	$ 31,855	$ 44,375

Acquisitions - Additional Infor

Acquisitions - Additional Information (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands					3 Months Ended	9 Months Ended
	Apr. 10, 2023	Feb. 17, 2023	Feb. 18, 2022	Dec. 21, 2021	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Business Acquisition [Line Items]
Goodwill					$ 244,927	$ 244,927	$ 155,998	$ 157,374
Denross Limited
Business Acquisition [Line Items]
Business acquisition, aggregate purchase price			$ 4,500
Business acquisition, cash payment		$ 375	3,100	$ 650
Business acquisition, cash in reserves			750
Business acquisition, purchase price allocation, assumed liabilities			166
Business acquisition, purchase price allocation, cash			4
Goodwill			4,645
Business acquisition, purchase price allocation, deferred tax asset			496
Business acquisition, purchase price allocation, tax asset valuation allowance			496
Business acquisition, purchase price allocation, other receivables			3
Denross Limited | Customer Relationship
Business Acquisition [Line Items]
Business acquisition, purchase price allocation, finite lived intangible assets			14
Checkweight Limited
Business Acquisition [Line Items]
Business acquisition, aggregate purchase price			1,500
Business acquisition, cash payment		$ 125	1,250
Business acquisition, cash in reserves			250
Business acquisition, purchase price allocation, assumed liabilities			56
Business acquisition, purchase price allocation, cash			4
Goodwill			1,291
Business acquisition, purchase price allocation, deferred tax asset			5
Business acquisition, purchase price allocation, tax asset valuation allowance			5
Business acquisition, purchase price allocation, other receivables			4
Checkweight Limited | Customer Relationship
Business Acquisition [Line Items]
Business acquisition, purchase price allocation, finite lived intangible assets			17
Checkweight Limited | Franchise Rights Acquired
Business Acquisition [Line Items]
Business acquisition, purchase price allocation, finite lived intangible assets			$ 240
Weekend Health, Inc. d/b/a Sequence
Business Acquisition [Line Items]
Business acquisition effective date	Apr. 10, 2023
Business acquisition, aggregate purchase price	$ 132,000
Business acquisition, cash payment	64,217
Business acquisition, purchase price allocation, cash	25,800
Business acquisition, amount to be paid one year from closing date	16,000
Business acquisition, amount to be paid two years from closing date	16,000
Total revenue					9,989	17,581
Net loss					3,133	4,763
Transaction related costs					$ 0	$ 8,605
Weekend Health, Inc. d/b/a Sequence | Common Stock
Business Acquisition [Line Items]
Business acquisition, equity interest issued as consideration for acquisition, value	$ 34,702
Business acquisition, equity interest issued as consideration for acquisition, shares	7,996
Business acquisition, common stock price per share	$ 4.34

Acquisitions - Summary of Purch

Acquisitions - Summary of Purchase Price Allocation for Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		Apr. 10, 2023	Sep. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Liabilities assumed:
Total goodwill			$ 244,927	$ 155,998	$ 157,374
Weekend Health, Inc. d/b/a Sequence
Total consideration:
Cash paid at closing		$ 64,217
Cash to be paid on April 10, 2024		16,000
Cash to be paid on April 10, 2025		16,000
Aggregated merger consideration		132,000
Assets acquired:
Cash		25,800
Weekend Health, Inc. d/b/a Sequence | Purchase Price Allocation
Total consideration:
Cash paid at closing		64,217
Cash to be paid on April 10, 2024		16,000
Cash to be paid on April 10, 2025	[1]	12,420
Total cash payments		92,637
Less stock-based compensation expense attributable to post combination vesting		(3,882)
Aggregated merger consideration		121,698
Assets acquired:
Cash		25,776
Prepaid expenses and other current assets		2,220
Property, plant and equipment		34
Intangible assets		7,768
Total assets acquired		35,798
Liabilities assumed:
Accounts payable		70
Accrued liabilities		14
Deferred revenue		1,300
Deferred tax liability		1,906
Total liabilities assumed		3,290
Net assets acquired		32,508
Total goodwill		$ 89,190
Weekend Health, Inc. d/b/a Sequence | Common Stock
Total consideration:
Common shares issued		7,996
Stock price as of April 10, 2023		$ 4.34
Weekend Health, Inc. d/b/a Sequence | Common Stock | Purchase Price Allocation
Total consideration:
Common shares issued		7,996
Stock price as of April 10, 2023	[2]	$ 4.12
Total stock issuance purchase price	[2]	$ 32,943
[1] Reflects $ 16,000 of cash payable on April 10, 2025 as Merger Consideration discounted using the Company's weighted average cost of debt. Represents the fair value of the shares transferred to the sellers, based on the number of shares to be issued, 7,996 , multiplied by the closing price of the Company's ordinary shares on April 10, 2023 of $ 4.12 per share.

Acquisitions - Summary of Pur_2

Acquisitions - Summary of Purchase Price Allocation for Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Parenthetical) (Detail) - Weekend Health, Inc. d/b/a Sequence $ / shares in Units, shares in Thousands, $ in Thousands	Apr. 10, 2023 USD ($) $ / shares shares
Business Acquisition [Line Items]
Cash to be paid on April 10, 2025 | $	$ 16,000
Common Stock
Business Acquisition [Line Items]
Common shares issued | shares	7,996
Stock price | $ / shares	$ 4.34
Purchase Price Allocation
Business Acquisition [Line Items]
Cash to be paid on April 10, 2025 | $	$ 12,420	[1]
Purchase Price Allocation | Common Stock
Business Acquisition [Line Items]
Common shares issued | shares	7,996
Stock price | $ / shares	$ 4.12	[2]
[1] Reflects $ 16,000 of cash payable on April 10, 2025 as Merger Consideration discounted using the Company's weighted average cost of debt. Represents the fair value of the shares transferred to the sellers, based on the number of shares to be issued, 7,996 , multiplied by the closing price of the Company's ordinary shares on April 10, 2023 of $ 4.12 per share.

Franchise Rights Acquired, Go_3

Franchise Rights Acquired, Goodwill and Other Intangible Assets - Change in Carrying Amount of Goodwill (Detail) - USD ($) $ in Thousands			9 Months Ended	12 Months Ended
	May 07, 2023	May 08, 2022	Sep. 30, 2023	Dec. 31, 2022
Goodwill [Line Items]
Beginning balance			$ 155,998	$ 157,374
Goodwill acquired during the period			89,190	5,936
Goodwill impairment	$ 0	$ 0		(3,124)
Effect of exchange rate changes			(261)	(4,188)
Ending balance			244,927	155,998
North America
Goodwill [Line Items]
Beginning balance			143,567	147,530
Goodwill acquired during the period			89,190
Goodwill impairment				(1,101)
Effect of exchange rate changes			(6)	(2,862)
Ending balance			232,751	143,567
International
Goodwill [Line Items]
Beginning balance			12,431	9,844
Goodwill acquired during the period				5,936
Goodwill impairment				(2,023)
Effect of exchange rate changes			(255)	(1,326)
Ending balance			$ 12,176	$ 12,431

Franchise Rights Acquired, Go_4

Franchise Rights Acquired, Goodwill and Other Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands				3 Months Ended			9 Months Ended		12 Months Ended
	May 07, 2023	May 08, 2022	Aug. 10, 2018	Sep. 30, 2023	Oct. 01, 2022	Jul. 02, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022	Jan. 01, 2022
Goodwill And Intangible Assets Disclosure [Line Items]
Finite-lived intangible assets, aggregate amortization expense				$ 13,628	$ 8,347		$ 32,590	$ 25,282
Goodwill				244,927			244,927		$ 155,998	$ 157,374
Franchise right maturity period	7 years
Goodwill impairment	$ 0	$ 0							$ 3,124
Kurbo Health, Inc
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill			$ 1,101
Net purchase price			$ 3,063
Kurbo, Inc
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill impairment						$ 1,101
United States
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill				104,020			104,020
Canada
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill				39,541			39,541
Other Countries
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill				$ 12,176			$ 12,176
All Reporting Units Except for Republic of Ireland
Goodwill And Intangible Assets Disclosure [Line Items]
Percentage of goodwill held				99.10%			99.10%
All Reporting Units Except for Republic of Ireland | Goodwill | Minimum
Goodwill And Intangible Assets Disclosure [Line Items]
Percentage of estimated fair value in excess of carrying amount	120%
Republic of Ireland
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill				$ 2,307			$ 2,307
Percentage of estimated fair value in excess of carrying amount	55%
Percentage of goodwill held				0.90%			0.90%
Franchise Rights Acquired
Goodwill And Intangible Assets Disclosure [Line Items]
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]	Asset Impairment Charges
Indefinite-lived intangible assets, impairment charges	$ 0
Assumed cumulative annual revenue growth rate	2.80%
Franchise Rights Acquired | Maximum
Goodwill And Intangible Assets Disclosure [Line Items]
Finite-lived intangible assets, estimated useful life (in years)				1 year			1 year
Assumed Workshops + Digital revenue growth rate	(18.40%)
Assumed operating income margin rates	12.70%
Assumed Digital revenue growth rate	7.50%
Franchise Rights Acquired | Minimum
Goodwill And Intangible Assets Disclosure [Line Items]
Assumed Workshops + Digital revenue growth rate	(37.10%)
Assumed operating income margin rates	(6.40%)
Assumed Digital revenue growth rate	(14.80%)
Franchise Rights Acquired | Other Units of Account
Goodwill And Intangible Assets Disclosure [Line Items]
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]		Asset Impairment Charges
Indefinite-lived intangible assets, impairment charges		$ 0
Franchise Rights Acquired | United States
Goodwill And Intangible Assets Disclosure [Line Items]
Net book value of franchise rights acquired				$ 374,354			$ 374,354
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]					Asset Impairment Charges
Indefinite-lived intangible assets, impairment charges					$ 298,291
Franchise Rights Acquired | Canada
Goodwill And Intangible Assets Disclosure [Line Items]
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]					Asset Impairment Charges	Asset Impairment Charges
Indefinite-lived intangible assets, impairment charges					$ 13,312	$ 24,485
Franchise Rights Acquired | United Kingdom
Goodwill And Intangible Assets Disclosure [Line Items]
Net book value of franchise rights acquired				2,688			2,688
Franchise Rights Acquired | Australia
Goodwill And Intangible Assets Disclosure [Line Items]
Net book value of franchise rights acquired				3,995			3,995
Franchise Rights Acquired | New Zealand
Goodwill And Intangible Assets Disclosure [Line Items]
Net book value of franchise rights acquired				$ 2,295			$ 2,295
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]					Asset Impairment Charges	Asset Impairment Charges
Indefinite-lived intangible assets, impairment charges					$ 1,138	$ 834
Percentage of estimated fair value in excess of carrying amount	20%
Percentage of franchise rights acquired				0.60%			0.60%
Franchise Rights Acquired | All Units of Account Except For New Zealand
Goodwill And Intangible Assets Disclosure [Line Items]
Percentage of franchise rights acquired				99.40%			99.40%
Franchise Rights Acquired | All Units of Account Except For New Zealand | Minimum
Goodwill And Intangible Assets Disclosure [Line Items]
Percentage of estimated fair value in excess of carrying amount	70%

Franchise Rights Acquired, Go_5

Franchise Rights Acquired, Goodwill and Other Intangible Assets - Schedule of Assumptions Utilized in Annual Goodwill Impairment Analysis (Details)	May 07, 2023	May 08, 2022
Assumptions Utilized in Annual Goodwill Impairment Analysis [Line Items]
Discount rate	10.80%	9.60%
Minimum
Assumptions Utilized in Annual Goodwill Impairment Analysis [Line Items]
Debt-Free Cumulative Annual Cash Flow Growth Rate	3.90%	1.20%
Maximum
Assumptions Utilized in Annual Goodwill Impairment Analysis [Line Items]
Debt-Free Cumulative Annual Cash Flow Growth Rate	24.90%	20.60%

Franchise Rights Acquired, Go_6

Franchise Rights Acquired, Goodwill and Other Intangible Assets - Schedule of Carrying Values of Finite-lived Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 308,560	$ 275,334
Accumulated Amortization	239,192	208,965
Capitalized software costs
Finite-Lived Intangible Assets
Gross Carrying Amount	109,250	107,229
Accumulated Amortization	101,753	94,375
Website development costs
Finite-Lived Intangible Assets
Gross Carrying Amount	164,975	133,818
Accumulated Amortization	113,570	91,482
Trademarks
Finite-Lived Intangible Assets
Gross Carrying Amount	12,177	12,162
Accumulated Amortization	12,003	11,882
Other
Finite-Lived Intangible Assets
Gross Carrying Amount	13,949	13,961
Accumulated Amortization	6,493	6,125
Trademarks and other intangible assets
Finite-Lived Intangible Assets
Gross Carrying Amount	300,351	267,170
Accumulated Amortization	233,819	203,864
Franchise Rights Acquired
Finite-Lived Intangible Assets
Gross Carrying Amount	8,209	8,164
Accumulated Amortization	$ 5,373	$ 5,101

Franchise Rights Acquired, Go_7

Franchise Rights Acquired, Goodwill and Other Intangible Assets - Schedule of Estimated Amortization Expense of Finite-lived Intangible Assets (Detail) $ in Thousands	Sep. 30, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of fiscal 2023	$ 10,937
Fiscal 2024	27,292
Fiscal 2025	17,679
Fiscal 2026	5,500
Fiscal 2027	725
Fiscal 2028	533
Thereafter	$ 6,702

Long-Term Debt - Components of

Long-Term Debt - Components of Long-Term Debt (Detail) - USD ($) $ in Thousands		Sep. 30, 2023	Dec. 31, 2022	Jul. 03, 2021
Debt Instrument
Total debt		$ 1,445,000	$ 1,445,000
Unamortized deferred financing costs		9,241	10,652
Unamortized debt discount		10,340	12,064
Total long term debt		$ 1,425,419	$ 1,422,284
Effective rate	[1]	7.48%	5.45%
Revolving Credit Facility due April 13, 2026
Debt Instrument
Total debt		$ 0	$ 0
Effective rate	[1]	0%	0%
Term Loan Facility due April 13, 2028
Debt Instrument
Total debt		$ 945,000	$ 945,000
Unamortized deferred financing costs		4,989	5,821
Unamortized debt discount		$ 10,340	$ 12,064	$ 5,000
Effective rate	[1]	8.99%	5.85%
Senior Secured Notes due April 15, 2029
Debt Instrument
Total debt		$ 500,000	$ 500,000
Unamortized deferred financing costs		$ 4,252	$ 4,831
Effective rate	[1]	4.65%	4.70%
[1] Includes amortization of deferred financing costs and debt discount.

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Mar. 30, 2025

Apr. 14, 2024

Jul. 01, 2023

Apr. 13, 2021 USD ($)

Dec. 31, 2021 USD ($)

Jan. 01, 2022 USD ($)

Jul. 03, 2021 USD ($)

Sep. 30, 2023 USD ($)

Mar. 29, 2025

Apr. 15, 2024

Mar. 30, 2024

Dec. 31, 2022 USD ($)

Debt Instrument

Loan outstanding amount

$ 1,445,000,000

$ 1,445,000,000

Aggregate principal amount

1,425,419,000

1,422,284,000

Fees incurred in connection with debt refinancing

$ 37,910,000

Unamortized debt discount

$ 10,340,000

$ 12,064,000

Loss on early extinguishment of debt

29,169,000

Financing costs in connection with debt refinancing

9,017,000

Write-off of pre-existing deferred financing fees and debt discount

7,213,000

Percentage of equity interests pledged

100%

Percentage of annual excess cash flow

50%

Percentage of annual excess cash flow after attaining first lien secured net leverage ratio one

25%

Percentage of annual excess cash flow after attaining first lien secured net leverage ratio two

0%

Percentage of net cash proceeds of certain non ordinary course asset sales by company and its restricted subsidiaries

100%

Percentage of right to invest of net cash proceeds of certain non ordinary course asset sales by company and its restricted subsidiaries subject to certain qualifications

100%

Percentage of net proceeds of any issuance or incurrence of debt by the Company or any of its restricted subsidiaries

100%

Effective Interest Rate

[1]

7.48%

5.45%

Average interest rate on outstanding debt, exclusive the impact of swap

7.48%

5.45%

Average interest rate on outstanding debt, including the impact of swap

6.44%

5.50%

One-Month Term Secured Overnight Financing Rate (SOFR)

Debt Instrument

Credit facility, interest rate

0.11448%

Three-Month Term Secured Overnight Financing Rate (SOFR)

Debt Instrument

Credit facility, interest rate

0.26161%

Six-Month Term Secured Overnight Financing Rate (SOFR)

Debt Instrument

Credit facility, interest rate

0.42826%

Twelve-Month Term Secured Overnight Financing Rate (SOFR)

Debt Instrument

Credit facility, interest rate

0.71513%

Maximum

Debt Instrument

Pledge percentage of first tier foreign subsidiaries directly owned by company or wholly owned subsidiaries

65%

4.500% Senior Secured Notes due 2029

Debt Instrument

Debt Instrument Interest Rate Stated Percentage

4.50%

Aggregate principal amount

$ 500,000,000

Senior Secured Tranche B Term Loan

Debt Instrument

Repayment of aggregate principal amount

$ 1,189,750,000

Debt Instrument, maturity year

2024

8.625% Senior Notes due in 2025

Debt Instrument

Debt Instrument, maturity year

2025

Debt instrument redeemed amount

$ 300,000,000

Debt Instrument Interest Rate Stated Percentage

8.625%

Fees incurred in connection with debt refinancing

12,939,000

Credit Facilities

Debt Instrument

Loan outstanding amount

$ 945,000,000

Proceeds received from long-term debt

$ 1,000,000,000

Senior Secured Revolving Credit Facility Due in 2022

Debt Instrument

Loan outstanding amount

$ 0

Term Loan Facility due April 13, 2028

Debt Instrument

Loan outstanding amount

945,000,000

$ 945,000,000

Unamortized debt discount

$ 5,000,000

$ 10,340,000

$ 12,064,000

Effective Interest Rate

[1]

8.99%

5.85%

Term Loan Facility due April 13, 2028 | Federal Funds Effective Rate

Debt Instrument

Credit facility, interest rate

0.50%

Term Loan Facility due April 13, 2028 | Secured Overnight Financing Rate (SOFR)

Debt Instrument

Credit facility, interest rate

1%

Debt instrument variable rate floor percent determined option one

0.50%

Effective Interest Rate

3.50%

Term Loan Facility due April 13, 2028 | Maximum | Secured Overnight Financing Rate (SOFR)

Debt Instrument

Debt instrument variable rate floor percent determined option one

1.50%

Senior Secured Notes due April 15, 2029

Debt Instrument

Debt Instrument Interest Rate Stated Percentage

4.50%

Loan outstanding amount

$ 500,000,000

$ 500,000,000

Effective Interest Rate

[1]

4.65%

4.70%

Debt instrument issued date

Apr. 13, 2021

Debt instrument, mature date

Apr. 15, 2029

Debt instrument interest payment term

Interest on the Senior Secured Notes is payable semi-annually on April 15 and October 15 of each year, beginning on October 15, 2021.

Debt Instrument, redemption, description

On or after April 15, 2024, the Company may on any one or more occasions redeem some or all of the Senior Secured Notes at a purchase price equal to 102.250% of the principal amount of the Senior Secured Notes, plus accrued and unpaid interest, if any, to, but not including, the redemption date, such optional redemption price decreasing to 101.125% on or after April 15, 2025 and to 100.000% on or after April 15, 2026. Prior to April 15, 2024, the Company may on any one or more occasions redeem up to 40% of the aggregate principal amount of the Senior Secured Notes with an amount not to exceed the net proceeds of certain equity offerings at 104.500% of the aggregate principal amount thereof, plus accrued and unpaid interest, if any, to, but not including, the redemption date. Prior to April 15, 2024, the Company may redeem some or all of the Senior Secured Notes at a make-whole price plus accrued and unpaid interest, if any, to, but not including, the redemption date. In addition, during any twelve-month period ending prior to April 15, 2024, the Company may redeem up to 10% of the aggregate principal amount of the Senior Secured Notes at a purchase price equal to 103.000% of the principal amount of the Senior Secured Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

Senior Secured Notes due April 15, 2029 | Change of Control

Debt Instrument

Debt instrument, percentage of aggregate principal amount that may be redeemed (up to)

101%

Senior Secured Notes due April 15, 2029 | Sale of Assets

Debt Instrument

Debt instrument, percentage of aggregate principal amount that may be redeemed (up to)

100%

Senior Secured Notes due April 15, 2029 | Debt Instrument Redemption Date, April 15, 2024

Debt Instrument

Debt Instrument, percentage of principal can be redeemed

102.25%

Debt Instrument, redemption date

Apr. 15, 2024

Senior Secured Notes due April 15, 2029 | Debt Instrument Redemption Date, April 15, 2025

Debt Instrument

Debt Instrument, percentage of principal can be redeemed

101.125%

Debt Instrument, redemption date

Apr. 15, 2025

Senior Secured Notes due April 15, 2029 | Debt Instrument Redemption Date, April 15, 2026

Debt Instrument

Debt Instrument, percentage of principal can be redeemed

100%

Debt Instrument, redemption date

Apr. 15, 2026

Senior Secured Notes due April 15, 2029 | Forecast

Debt Instrument

Debt Instrument, percentage of principal can be redeemed

103%

Senior Secured Notes due April 15, 2029 | Maximum | Forecast

Debt Instrument

Debt Instrument, percentage of principal can be redeemed

104.50%

Percent of principal amount of debt that may be redeemed (up to)

40%

Debt instrument, percentage of aggregate principal amount that may be redeemed (up to)

10%

Credit Facilities and Senior Secured Notes

Debt Instrument

Loan outstanding amount

$ 1,445,000,000

Revolving Credit Facility

Debt Instrument

Credit Facility, maximum borrowing capacity

61,250,000

Loan outstanding amount

0

$ 0

Aggregate principal amount

0

$ 0

Credit facility available amount

173,921,000

Line of credit facility, issued but undrawn letters of credit

$ 1,079,000

Effective Interest Rate

[1]

0%

0%

Minimum outstanding amount to compliance springing maintenance covenant

35%

Consolidated first lien leverage ratio

8.64

Revolving Credit Facility | Forecast

Debt Instrument

Consolidated first lien leverage ratio compliance

5

5.25

5.50

Revolving Credit Facility | Federal Funds Effective Rate

Debt Instrument

Credit facility, interest rate

0.50%

Revolving Credit Facility | Secured Overnight Financing Rate (SOFR)

Debt Instrument

Credit facility, interest rate

1%

Debt instrument variable rate floor percent determined option one

0%

Effective Interest Rate

2.75%

Revolving Credit Facility | Maximum | Secured Overnight Financing Rate (SOFR)

Debt Instrument

Debt instrument variable rate floor percent determined option one

1%

Revolving Credit Facility | Senior Secured Revolving Credit Facility Due in 2022

Debt Instrument

Debt Instrument, maturity year

2022

Credit Facility, maximum borrowing capacity

$ 175,000,000

Revolving Credit Facility | Senior Secured Revolving Credit Facility

Debt Instrument

Debt Instrument, maturity year

2026

Credit Facility, maximum borrowing capacity

$ 175,000,000

Term Loan Facility | Senior Secured Tranche B Term Loan

Debt Instrument

Debt Instrument, maturity year

2028

Credit Facility, maximum borrowing capacity

$ 1,000,000,000

Write-off of pre-existing deferred financing fees and debt discount

$ 1,183,000

Prepayments of aggregate principal amount

$ 52,500,000

[1] Includes amortization of deferred financing costs and debt discount.

Per Share Data - Computation of

Per Share Data - Computation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Numerator:
Net income (loss)	$ 43,731	$ (35,780)	$ (206,036)	$ (24,120)	$ (221,087)	$ (256,868)
Denominator:
Weighted average shares of common stock outstanding	78,979		70,383	75,861	70,258
Effect of dilutive common stock equivalents	1,659
Weighted average diluted common shares outstanding	80,638		70,383	75,861	70,258
Earnings (net loss) per share
Basic	$ 0.55	$ (0.51)	$ (2.93)	$ (0.32)	$ (3.15)	$ (3.65)
Diluted	$ 0.54	$ (0.51)	$ (2.93)	$ (0.32)	$ (3.15)	$ (3.65)

Per Share Data - Additional Inf

Per Share Data - Additional Information (Detail) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Earnings Per Share [Abstract]
Anti-dilutive common stock equivalents excluded from the calculation of diluted earnings (net loss) per share	6,770	9,229	9,341	8,307

Taxes - Additional Information

Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 01, 2023	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Effective income tax rate	(727.70%)		25.60%		44%	24.90%
(Benefit from) provision for income taxes	$ (38,447)	$ (36,689)	$ (70,749)	$ 19,515	$ (18,933)	$ (73,246)	$ (109,935)

Derivative Instruments and He_3

Derivative Instruments and Hedging - Additional Information (Detail) - USD ($) $ in Thousands					9 Months Ended
	Mar. 31, 2021	Apr. 02, 2020	Jun. 07, 2019	Jun. 11, 2018	Sep. 30, 2023	Dec. 31, 2022
Derivative
Maximum length of time hedging forecasted					1 year
Net derivative gains included in accumulated other comprehensive loss expected to be reclassified into earnings within the next 12 months, net of tax					$ 7,926
Net derivative gains included in accumulated other comprehensive loss expected to be reclassified into earnings within the next 12 months, before tax					10,569
Interest Rate Swap
Derivative
Cumulative unrealized gain for qualifying hedges reported as a component of accumulated other comprehensive loss, net of tax					5,507	$ 10,723
Cumulative unrealized gain for qualifying hedges reported as a component of accumulated other comprehensive loss, before tax					7,192	14,146
Interest Rate Swap | 2018 Swap
Derivative
Forward-starting interest rate swap, effective date				Apr. 02, 2020
Forward starting interest rate swap, termination date				Mar. 31, 2024
Derivative interest rate swap percentage				3.1513%
Interest Rate Swap | 2019 Swap
Derivative
Forward-starting interest rate swap, effective date			Apr. 02, 2020
Forward starting interest rate swap, termination date			Mar. 31, 2024
Derivative interest rate swap percentage			1.9645%
Interest Rate Swap | Cash Flow Hedging
Derivative
Notional amount					$ 500,000	$ 500,000
Interest Rate Swap | Cash Flow Hedging | 2018 Swap
Derivative
Notional amount	$ 250,000	$ 500,000		$ 500,000
Forward-starting interest rate swap, effective date	Mar. 31, 2021	Apr. 02, 2020
Interest Rate Swap | Cash Flow Hedging | 2019 Swap
Derivative
Notional amount			$ 250,000

Derivative Instruments and He_4

Derivative Instruments and Hedging - Aggregate Fair Value of Derivative Financial Instruments by Balance Sheet Classification and Location (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Derivative
Derivative assets	$ 7,272	$ 14,198
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Assets	Assets
Interest Rate Swap - Current Swaps
Derivative
Derivative assets, current	$ 7,272	$ 11,748
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Prepaid Expense and Other Assets, Current	Prepaid Expense and Other Assets, Current
Derivative assets, noncurrent		$ 2,450
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Other Assets, Noncurrent

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Debt outstanding amount	$ 1,425,419,000	$ 1,422,284,000
Fair value of long-term debt	1,058,128,000	782,384,000
Fair value assets, transfer between level 1 to level 2	0	0
Fair value liabilities, transfer between level 1 to level 2	0	0
Fair value assets, transfer between level 2 to level 1	0	0
Fair value liabilities, transfer between level 2 to level 1	0	0
Revolving Credit Facility
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Carrying value of long-term debt	0	0
Debt outstanding amount	$ 0	$ 0

Fair Value Measurements - Aggre

Fair Value Measurements - Aggregate Fair Value of Derivative Financial Instruments (Detail) - Fair Value, Measurements, Recurring - Interest Rate Swap - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Interest rate swap current asset	$ 7,272	$ 11,748
Interest rate swap noncurrent asset		2,450
Fair Value Measurements Using Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Interest rate swap current asset	$ 7,272	11,748
Interest rate swap noncurrent asset		$ 2,450

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Changes in Accumulated Other Comprehensive Loss by Component (Detail) - USD ($) $ in Thousands		9 Months Ended
		Sep. 30, 2023	Oct. 01, 2022
Accumulated Other Comprehensive Income Loss [Line Items]
Other comprehensive income (loss) before reclassifications, net of tax	[1]	$ 496	$ 3,862
Amounts reclassified from accumulated other comprehensive loss, net of tax	[1],[2]	(6,994)	3,425
Net current period other comprehensive income (loss)	[1]	(6,498)	7,287
(Loss) Gain on Qualifying Hedges
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	[1]	10,723	(10,843)
Other comprehensive income (loss) before reclassifications, net of tax	[1]	1,778	17,350
Amounts reclassified from accumulated other comprehensive loss, net of tax	[1],[2]	(6,994)	3,425
Net current period other comprehensive income (loss)	[1]	(5,216)	20,775
Ending balance	[1]	5,507	9,932
Loss on Foreign Currency Translation
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	[1]	(16,193)	(7,761)
Other comprehensive income (loss) before reclassifications, net of tax	[1]	(1,282)	(13,488)
Net current period other comprehensive income (loss)	[1]	(1,282)	(13,488)
Ending balance	[1]	(17,475)	(21,249)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	[1]	(5,470)	(18,604)
Ending balance	[1]	$ (11,968)	$ (11,317)
[1] Amounts in parentheses indicate debits See separate table below for details about these reclassifications

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss - Reclassifications out of Accumulated Other Comprehensive Loss (Detail) - Interest Rate Contracts - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Interest Expense
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items]
Gain (Loss) on Qualifying Hedges	[1]	$ 3,559	$ (326)	$ 9,327	$ (4,575)
Income (Loss) before Income Taxes
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items]
Gain (Loss) on Qualifying Hedges	[1]	3,559	(326)	9,327	(4,575)
Benefit from Income Taxes
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items]
Gain (Loss) on Qualifying Hedges	[1]	(890)	82	(2,333)	1,150
Net Income (Loss)
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items]
Gain (Loss) on Qualifying Hedges	[1]	$ 2,669	$ (244)	$ 6,994	$ (3,425)
[1] Amounts in parentheses indicate debits to profit/loss

Segment Data - Additional Infor

Segment Data - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2023 Segment
Segment Reporting [Abstract]
Number of reportable segments	2

Segment Data - Information Abou

Segment Data - Information About Reportable Segments (Detail) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 01, 2023	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Segment Reporting Information [Line Items]
Revenues, net	$ 214,871	$ 222,903	$ 249,718		$ 683,594	$ 816,932	$ 1,039,835
Operating income (loss)	30,607	(51,777)	(254,529)		28,340	(232,193)	(283,971)
Interest expense	24,508		20,912		71,429	58,837
Other expense (income), net	815		1,344		(36)	3,303
(Benefit from) provision for income taxes	(38,447)	(36,689)	(70,749)	$ 19,515	(18,933)	(73,246)	(109,935)
Net income (loss)	43,731	$ (35,780)	(206,036)		(24,120)	(221,087)	$ (256,868)
Depreciation and amortization	16,191		11,833		43,568	37,134
Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	59,739		(226,028)		137,647	(129,823)
Depreciation and amortization	8,760		8,301		25,506	26,085
General Corporate
Segment Reporting Information [Line Items]
General corporate expenses	29,132		28,501		109,307	102,370
Depreciation and amortization	7,431		3,532		18,062	11,049
North America
Segment Reporting Information [Line Items]
Revenues, net	154,687		176,469		487,900	569,525
North America | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	36,064		(255,102)		81,850	(207,039)
Depreciation and amortization	8,523		7,939		24,719	24,738
International
Segment Reporting Information [Line Items]
Revenues, net	60,184		73,249		195,694	247,407
International | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	23,675		29,074		55,797	77,216
Depreciation and amortization	$ 237		$ 362		$ 787	$ 1,347

Related Party - Additional Info

Related Party - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Oct. 18, 2015	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Initial agreement term	5 years
Services provided by related party		$ 63,034	$ 58,443	$ 188,638	$ 193,320
Ms. Winfrey And Her Related Entities | Related Party
Related Party Transaction [Line Items]
Services provided by related party		62	$ 284	384	$ 860
Accounts payable to related party		$ 61		$ 61		$ 0

Restructuring - Additional Info

Restructuring - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
2023 Plan
Restructuring Cost And Reserve [Line Items]
Restructuring charges	$ 6,187	$ 30,603		$ 13,608
Restructuring charges after tax	4,640	22,949		10,201
2023 Plan | Real Estate Restructuring | Lease Termination and Other Related Costs
Restructuring Cost And Reserve [Line Items]
Restructuring charges	(523)	14,371
Restructuring charges after tax	(392)	10,777
Payments		11,224
Provision estimates		67
Restructuring liability	528	528
2023 Plan | Real Estate Restructuring | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Restructuring charges	562	4,825		1,798
Restructuring charges after tax	421	3,618		1,348
Payments		4,347
Restructuring liability	2,275	2,275
2023 Plan | Organizational Restructuring | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Restructuring charges	4,025	8,901		11,810
Restructuring charges after tax	3,018	6,675		8,853
Payments		11,172
Restructuring liability	9,539	9,539
2023 Plan | Other Costs | Scenario Forecast
Restructuring Cost And Reserve [Line Items]
Estimated cost			$ 3,000
Revised estimated cost			4,000
2023 Plan | Minimum | Scenario Forecast
Restructuring Cost And Reserve [Line Items]
Estimated cost			39,000
Revised estimated cost			47,000
2023 Plan | Minimum | Real Estate Restructuring | Scenario Forecast
Restructuring Cost And Reserve [Line Items]
Estimated cost			20,000
Revised estimated cost			22,000
2023 Plan | Minimum | Organizational Restructuring | Scenario Forecast | General and Administrative Expenses
Restructuring Cost And Reserve [Line Items]
Estimated cost			16,000
Revised estimated cost			21,000
2023 Plan | Maximum | Scenario Forecast
Restructuring Cost And Reserve [Line Items]
Estimated cost			46,000
Revised estimated cost			54,000
2023 Plan | Maximum | Real Estate Restructuring | Scenario Forecast
Restructuring Cost And Reserve [Line Items]
Estimated cost			24,000
Revised estimated cost			24,000
2023 Plan | Maximum | Organizational Restructuring | Scenario Forecast | General and Administrative Expenses
Restructuring Cost And Reserve [Line Items]
Estimated cost			19,000
Revised estimated cost			$ 26,000
2022 Plan
Restructuring Cost And Reserve [Line Items]
Restructuring charges				27,181
Restructuring charges after tax				20,375
2022 Plan | Lease Termination and Other Related Costs
Restructuring Cost And Reserve [Line Items]
Restructuring charges				3,791
Payments		122		1,877
Provision estimates		(425)
Restructuring liability	0	0
2022 Plan | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Restructuring charges				19,170
Payments		7,636		10,909
Provision estimates		1,067
Restructuring liability	1,692	1,692
2021 Plan
Restructuring Cost And Reserve [Line Items]
Restructuring charges					$ 21,534
Restructuring charges after tax					16,109
2021 Plan | Lease Termination and Other Related Costs
Restructuring Cost And Reserve [Line Items]
Restructuring charges				119	12,688
Payments				777	7,640
Provision estimates				(681)	(3)
Restructuring liability	0	0
2021 Plan | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Restructuring charges				148	8,846
Payments		507		3,814	4,802
Provision estimates		57		72
Restructuring liability	0	0
2020 Plan
Restructuring Cost And Reserve [Line Items]
Restructuring charges						$ 33,092
Restructuring charges after tax						24,756
2020 Plan | Lease Termination and Other Related Costs
Restructuring Cost And Reserve [Line Items]
Restructuring charges						7,989
Payments				86	4,649	645
Provision estimates				(116)	(470)
Restructuring liability	0	0
2020 Plan | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Restructuring charges						25,103
Payments		97		1,202	6,773	15,434
Provision estimates		(20)		$ (621)	$ (1,136)	$ 180
Restructuring liability	$ 0	$ 0

Restructuring - Components of R

Restructuring - Components of Restructuring Charges (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
2023 Plan
Restructuring Cost And Reserve [Line Items]
Total restructuring charges	$ 6,187	$ 30,603	$ 13,608
2023 Plan | Other Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges	2,123	2,506
2023 Plan | Real Estate Restructuring | Lease Termination and Other Related Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges	(523)	14,371
2023 Plan | Real Estate Restructuring | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges	562	4,825	1,798
2023 Plan | Organizational Restructuring | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges	$ 4,025	$ 8,901	11,810
2022 Plan
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			27,181
2022 Plan | Lease Termination and Other Related Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			3,791
2022 Plan | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			19,170
2022 Plan | Lease Impairments
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			2,680
2022 Plan | Other Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			1,540
2021 Plan
Restructuring Cost And Reserve [Line Items]
Total restructuring charges				$ 21,534
2021 Plan | Lease Termination and Other Related Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			119	12,688
2021 Plan | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			$ 148	$ 8,846
2020 Plan
Restructuring Cost And Reserve [Line Items]
Total restructuring charges					$ 33,092
2020 Plan | Lease Termination and Other Related Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges					7,989
2020 Plan | Employee Termination Benefit Costs
Restructuring Cost And Reserve [Line Items]
Total restructuring charges					$ 25,103

Restructuring - Schedule of Res

Restructuring - Schedule of Restructuring Charges (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
2023 Plan
Restructuring Cost And Reserve [Line Items]
Total restructuring charges	$ 6,187	$ 30,603	$ 13,608
2023 Plan | Cost of Revenues
Restructuring Cost And Reserve [Line Items]
Total restructuring charges	444	19,869	1,798
2023 Plan | Selling, General and Administrative Expenses
Restructuring Cost And Reserve [Line Items]
Total restructuring charges	$ 5,743	$ 10,734	11,810
2022 Plan
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			27,181
2022 Plan | Cost of Revenues
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			6,476
2022 Plan | Selling, General and Administrative Expenses
Restructuring Cost And Reserve [Line Items]
Total restructuring charges			$ 20,705
2021 Plan
Restructuring Cost And Reserve [Line Items]
Total restructuring charges				$ 21,534
2021 Plan | Cost of Revenues
Restructuring Cost And Reserve [Line Items]
Total restructuring charges				16,727
2021 Plan | Selling, General and Administrative Expenses
Restructuring Cost And Reserve [Line Items]
Total restructuring charges				$ 4,807
2020 Plan
Restructuring Cost And Reserve [Line Items]
Total restructuring charges					$ 33,092
2020 Plan | Cost of Revenues
Restructuring Cost And Reserve [Line Items]
Total restructuring charges					23,300
2020 Plan | Selling, General and Administrative Expenses
Restructuring Cost And Reserve [Line Items]
Total restructuring charges					$ 9,792

Revision of Previously Issued_3

Revision of Previously Issued Financial Statements - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Jul. 01, 2023	Jan. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Jan. 01, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total stockholders' equity	$ (675,167)	$ (718,227)		$ (685,780)	$ (658,188)	$ (454,793)	$ (452,904)
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total stockholders' equity				(1,965)
Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total stockholders' equity	$ 2,409,997	$ 2,368,375		$ 2,416,994	$ 2,459,227	$ 2,663,133	$ 2,685,849
Retained Earnings | Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total stockholders' equity			$ 5,465
Retained Earnings | Adjustments | Income Tax Misstatement
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total stockholders' equity			1,965
Retained Earnings | Adjustments | Other Misstatements
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total stockholders' equity			$ 3,500

Revision of Previously Issued_4

Revision of Previously Issued Financial Statements - Statement of Operations (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 01, 2023	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenues, net	$ 214,871	$ 222,903	$ 249,718		$ 683,594	$ 816,932	$ 1,039,835
Gross profit	141,755	125,969	152,351		404,446	495,411	621,379
Operating income (loss)	30,607	(51,777)	(254,529)		28,340	(232,193)	(283,971)
Income (loss) before income taxes	5,284	(72,469)	(276,785)		(43,053)	(294,333)	(366,803)
(Benefit from) provision for income taxes	(38,447)	(36,689)	(70,749)	$ 19,515	(18,933)	(73,246)	(109,935)
Net income (loss)	$ 43,731	$ (35,780)	$ (206,036)		$ (24,120)	$ (221,087)	$ (256,868)
Earnings (net loss) per share
Basic	$ 0.55	$ (0.51)	$ (2.93)		$ (0.32)	$ (3.15)	$ (3.65)
Diluted	$ 0.54	$ (0.51)	$ (2.93)		$ (0.32)	$ (3.15)	$ (3.65)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenues, net		$ 223,924					$ 1,040,856
Gross profit		126,990					622,400
Operating income (loss)		(50,756)					(282,950)
Income (loss) before income taxes		(71,448)					(365,782)
(Benefit from) provision for income taxes		(38,948)				$ (75,431)	(114,379)
Net income (loss)		$ (32,500)				$ (218,902)	$ (251,403)
Earnings (net loss) per share
Basic		$ (0.46)				$ (3.12)	$ (3.58)
Diluted		$ (0.46)				$ (3.12)	$ (3.58)
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenues, net		$ (1,021)					$ (1,021)
Gross profit		(1,021)					(1,021)
Operating income (loss)		(1,021)					(1,021)
Income (loss) before income taxes		(1,021)					(1,021)
(Benefit from) provision for income taxes		2,259				$ 2,185	4,444
Net income (loss)		$ (3,280)				$ (2,185)	$ (5,465)
Earnings (net loss) per share
Basic		$ (0.05)				$ (0.03)	$ (0.08)
Diluted		$ (0.05)				$ (0.03)	$ (0.08)

Revision of Previously Issued_5

Revision of Previously Issued Financial Statements - Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Income (Loss)	$ 43,731	$ (35,780)	$ (206,036)	$ (24,120)	$ (221,087)	$ (256,868)
Comprehensive (loss) income	$ 39,292		$ (206,751)	$ (30,618)	(213,800)	(243,734)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Income (Loss)		(32,500)			(218,902)	(251,403)
Comprehensive (loss) income					(211,615)	(238,269)
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Income (Loss)		$ (3,280)			(2,185)	(5,465)
Comprehensive (loss) income					$ (2,185)	$ (5,465)

Revision of Previously Issued_6

Revision of Previously Issued Financial Statements - Cash Flows (Detail) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Income (Loss)	$ 43,731	$ (35,780)	$ (206,036)	$ (24,120)	$ (221,087)	$ (256,868)
Changes in cash due to:
Prepaid expenses				(27,301)	17,613	8,878
Accrued liabilities				(17,010)	15,390	20,925
Income taxes				(1,104)	1,793	4,577
Cash (used for) provided by operating activities				$ (1,153)	80,546	76,646
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Income (Loss)		(32,500)			(218,902)	(251,403)
Changes in cash due to:
Prepaid expenses						9,599
Accrued liabilities						19,904
Income taxes					(392)	(588)
Cash (used for) provided by operating activities					80,546	76,646
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Income (Loss)		$ (3,280)			(2,185)	(5,465)
Changes in cash due to:
Prepaid expenses						(721)
Accrued liabilities						1,021
Income taxes					$ 2,185	$ 5,165

Revision of Previously Issued_7

Revision of Previously Issued Financial Statements - Balance Sheet (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Jul. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Jan. 01, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Deferred income taxes	$ 15,932		$ 25,084
Total Liabilities	1,707,420		1,714,210
Retained earnings	2,409,997		2,416,994
Total Deficit	$ (675,167)	$ (718,227)	(685,780)	$ (658,188)	$ (454,793)	$ (452,904)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Deferred income taxes			23,119
Total Liabilities			1,712,245
Retained earnings			2,418,959
Total Deficit			(683,815)
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Deferred income taxes			1,965
Total Liabilities			1,965
Retained earnings			(1,965)
Total Deficit			$ (1,965)